Клинико-нейропсихологические и нейровизуализационные аспекты дифференциальной диагностики паркинсонизма
Диссертация
Паркинсонизм относится к числу наиболее часто встречающихся в клинической практике неврологических синдромов, распространенность которого достигает 500 человек на 100 ООО населения. Паркинсонизм — синдром, который может быть проявлением нескольких десятков заболеваний головного мозга, преимущественно поражающих базапьные ганглии. Многочисленные эпидемиологические и клинико-патоморфологические… Читать ещё >
Содержание
- Глава 1. Общие подходы к синдромологической и нозологической диагностике паркинсонизма (обзор литературы)
- Глава 2. Материалы и методы
- Глава 3. Особенности неврологических, нейропсихологических, нейровизуализационных проявлений при болезни Паркинсона
- 3. 1. Двигательные нарушения у больных болезнью Паркинсона
- 3. 2. Вегетативные нарушения при болезни Паркинсона
- 3. 3. Нейропсихологические нарушения у больных болезнью Паркинсона
- 3. 4. Исследование психомоторных функций у больных болезнью Паркинсона
- 3. 5. Нейровизуализационные изменения при болезни Паркинсона
- Глава 4. Особенности неврологических, нейропсихологических и нейровизуализационных проявлений при мультисистемных дегенерациях ЦНС
- 4. 1. Неврологические, нейропсихологические и нейровизуализационные проявления при прогрессирующем надъядерном параличе
- 4. 2. Неврологические, нейропсихологические и нейровизуализационные проявления при мультисистемной атрофии
- 4. 3. Неврологические, нейропсихологические и нейровизуализационные проявления при болезни диффузных телец Леви
- 4. 4. Неврологические, нейропсихологические и нейровизуализационные проявления при кортикобазальной дегенерации
- 4. 5. Неврологические, нейропсихологические и нейровизуализационные проявления при болезни Альцгеймера с паркинсонизмом
- 4. 6. Сопоставление неврологических, нейропсихологических и нейровизуализационных изменений у больных с мультисистемными дегенерациями
- Глава 5. Особенности неврологических, нейропсихологических и нейровизуализационных проявлений при вторичном паркинсонизме
- 5. 1. Неврологические, нейропсихологические и нейровизуализационные проявления при сосудистом паркинсонизме
- 5. 2. Особенности неврологических нарушений при лекарственном паркинсонизме
- 5. 3. Неврологические, нейропсихологические и нейровизуализационные проявления при эфедроновой энцефалопатии
- 5. 4. Неврологические, нейропсихологические и нейровизуализационные проявления при нормотензивной гидроцефалии
- 5. 5. Неврологические, нейропсихологические и нейровизуализационные проявления при посттравматическом паркинсонизме
- Глава 6. Данные однофотонной эмиссионной компьютерной томографии с
- Тс 99]-ГМПО при паркинсонизме различной этиологии и их роль в дифференциальной диагностике паркинсонизма
- Глава 7. Особенности биоэлектрической мышечной активности при болезни Паркинсона, мультисистемной атрофии и прогрессирующем надъядерном параличе
- Глава 8. Эффективность дофаминергических средств как критерий дифференциальной диагностики при паркинсонизме
- Глава 9. Обсуждение полученных данных и построение алгоритма дифференциальной диагностики паркинсонизма
Список литературы
- Алимова Е.Я., Голубев В. Л. Вегетативные нарушения при паркинсонизме//Журн. невропат, и психиатр.-1992.-№ 5−12-С.48−52.
- Андреева Е.А., Хуторская O.E. Спектральный метод анализа электромиографической активности мышц//.М.Наука 1987. 156 С.
- Анохин П.К. Узловые вопросы теории функциональных систем. М.: Медицина, 1978. -304 с.
- Артемьев Д.В., Голубев В. Л. Заболевания с преимущественным поражением экстрапирамидной нервной системы.//Заболевания нервной системы. Под ред. Н. Н. Яхно, Д. Р. Штульмана. М., 2002.
- Артемьев Д.В. Возрастные аспекты болезни Паркинсона.//Автореф. дис. канд. мед. наук. — М&bdquo- 1995.
- Артемьев Д.В., Глозман Ж. М. Нарушения высших психических функций при болезни Паркинсона//Достижения в нейрогериартрии/Под ред. Н. Н. Яхно, И. В. Дамулина.-М., 1995.-С.46−60.
- Артемьев Д. В. Дамулин И.В., Яхно H.H. Применение препарата синемет-CR в лечении болезни Паркинсона//Журн. невропатол. и психиатр.-1995.-Т. 95.-№ 5.-С. 31−35.
- Арушанян Э. Б. Отеллин В.А. Хвостатое ядро//Л.: Наука, 1976.-С. 223.
- Атаджанов М.А. Экспериментальное моделирование паркинсонического синдрома и его комплексная патогенетическая терапия//Автореф. дис. докт.мед.наук.-М., 1989. Ю. Бархатова В. П. Нейротрансмиттеры и экстрапирамидная патология. М.:Медицина, 1988. -175С.
- КБернштейн H.A. Очерки по физиологии движений и физиологии активности//М.: Медицина, 1966.-С. 349.
- Бернштейн H.A. Физиология движений и активность. М.: Наука, 1990. 495 С. 1 З. Бехтерева Н. П., Бондарчук А. Н., Смирнов В. М., Трохачев А. И. Физиология и патофизиология глубоких структур мозга человека. М.-Л.: Медицина, 1967.-259 С.
- Бичева К.Г. Факторы инвапидизации при болезни Паркинсона и подходы к их коррекции//Автореф. дис. канд.мед.наук.-М., 1998.
- Боголепов Н.К. Атеросклеротический паркинсонизм//Нарушения мозгового кровообращения.-М., 1968.-Вып.1.-С. 37−46.
- Боголепов Н.К. Нарушения двигательных функций при сосудистых поражениях головного мозга. М.:Медгиз, 1953. -401 с.
- П.Боголепов Н. К., Арбатская Ю. Д., Гапонова Ю. Г. Клиника и экспертиза трудоспособности больных с посттравматическим и постэнцефалитическим паркинсонизмом и вопросы дифференциальной диагностики//Журн. невропатол. и психиатр, — 1970, — № 2.-С. 1325−1334.
- Вайншток А.Б., Олейник Л. И. Дифференциальная диагностика и современные методы лекарственного лечения паркинсонизма (Методическое письмо).-Киев, 1971.- 36с.
- Вейн A.M. Лекции по неврологии неспецифичских систем мозга.М., 1974.- 120с.
- Вейн А. М (ред.).Вегетативные расстройства. М.: МИА, 1998. -749 с.
- Вейн A.M., Вознесенская Т. Г. Голубев В.Л., Дюкова Г. М. Депрессия в неврологической практике//М" 1998.-С. 126.
- Вейн A.M., Голубев В. Л., Берзиньш Ю. Э. Паркинсонизм. Клиника, этиология, патогенез, лечение. Рига, Зинатне, 1981.- 326 с.
- Вейн A.M., Голубев В. Л., Яхно H.H. Паркинсонизм с позиций функционально-неврологического анализа//Паркинсонизм (вопросы клиники, патогенеза и лечения).- М., 1974,-С. 57−65.
- Верещагин Н.В., Брагина Л. К., Вавилов С. Б. Левина Г. Л. Компьютерная томография мозга. М.: Медицина, 1986.
- Верещагин Н.В., Моргунов В. А., Гулевская Т. С. Патология головного мозга при атеросклерозе и артериальной гипертониию М.: Медицина, 1997. 287 с
- Выготский Л.С. Проблемы дефектологии. М.:Просвещение, 1985. -С.402−403.
- Глозман Ж.М. Кому и как ставить диагноз деменции? Мнение нейропсихолога. // В кн.: Н. Н. Яхно, И. В. Дамулин. Достижения в нейрогериатрии. М., 1995. С.61−70.
- Глозман Ж.М., Артемьев Д. В., Дамулин И. В. и соавт. Возрастные особенности нейропсихологических расстройств при болезни Паркинсона .// Вестник МГУ, Психология, 1994.-№ З.-С. 25−36.
- Глозман Ж.М., Шток В. Н., Салтыкова Н. М. и соавт. Клинико-психологическое исследование депрессивного синдрома при паркинсонизме //Вестник Московского университета, сер. 14,1995.-N3.-С. 29−36.
- Голубев B. J1. Клинико-физиологический анализ синдрома паркинсонизма в цикле сон-бодрствование//Дис.. канд.мед.наук.- М., 1974.
- Голубев В.Л., Левин Я. И., Вейн A.M. Болезнь Паркинсона и синдром паркинсонизма//М.: МЕДпресс, 1999.-С 416.
- Голубев В.Л., Левин Я. И., Шамликашвили Ц. А. Латерализованные формы паркинсонизма (клинические, электроэнцефалографические и психомоторные аспекты)//Журн. невропат. и психиатр.-! 989.-№ 11.-С. 119−123.
- Голубев В.Л., Левин Я. И., Шамликашвили Ц. А., Алимова Е. Я. Вегетативные нарушения при паркинсонизме//Журн. невропат, и психиатр, — 1989,-№ 10.- С. 35−38.
- Гурфинкель B.C., Коц Я.М., Шик М. Л. Регуляция позы человека, — М.: Наука., 1965.-256 с.
- Гурфинкель B.C., Левик Ю. С. Система внутреннего представления и управление движениями//Вестник РАН, 1995. -Т.65. -№ 1. -С.29.
- Дамулин И.В. Дисциркуляторная энцефалопатия в пожилом и старческом возрасте//Автореф.дис.. докт.мед.наук.-М., 1997.
- Дамулин И.В., Павлова А. И. Деменция лобного типа.// Неврологический журнал, 1997. -№ 1. -С.37−42.
- Данаилова Д.П. Расстройства внимания у больных паркинсонизмом.//Журнал невропатологии и психиатрии им. С. С. Корсакова.-l 080.-№ 5.-С.694−696.
- Дехтерев В.В. Дрожательный паралич, — М., 1927, — 226 с.
- Доброхотова Т.А., Брагина H.H. Функциональная асимметрия и психопатология очаговых поражений мозга,— М.: Медицина, 1977.-359 с.
- Елкин М.Н. Множественная системная атрофия // Неврологический журнал, 1997. -№ 6. с. 35−38.
- Елкин М.Н., Количественные характеристики ЭЭГ при паркинсонизме: связь с клиническими, когнитивными, возрастными особенностями//Автореф.дис.. канд.мед.наук.-М" 1996.
- Жученко Т.Д., Вейн A.M., Голубев В. Л. и др. Сосудистый паркинсонизм//Журн. невропат, и психиатр, — 1998,-№ 4, — С.62−65.
- Захаров В.В. Нарушение мнестической функции при паркинсонизме.//Автореф. дис.. канд.мед.наук.—М., 1996
- Иванова-Смоленская И.А., Маркова Е. Д., Иллариошкин С. Н. Моногенные наследственные болезни нервной системы // В кн.: Наследственные болезни нервной системы. Под ред. Ю. Е. Вельтищева, П. А. Тёмина. М., Медицина, 1998. — С. 9−105.
- Иценко Н.М. Клиника и патологическая анатомия хронического эпидемического энцефалита (синдром скованности) в связи с учением об экстрапирамидной системе.- Ростов н/Дону, 1926.-41с.
- Кадыков A.C., Калашникова Л. А., Альберт М. В. Синдром гемипаркинсонизма-гемиатрофии. Неврологический журнал 1998.- N5. -С.10−13.
- Кадыков А. С, Калашникова Л. А., Шахпаронова Н. В. и соавт. Сосудистый паркинсонизм: особенности клиники, течения, диагностики и лечения.//УШ Всероссийский съезд неврологов. Казань, 2001.-С.357.
- Кадыков A.C., Переседова A.B. Прогрессирующий надъядерный паралич (описание 2 случаев). // Неврологический журнал, 1997. № 6. -С.9−13.
- Каменецкий В.К. Паркинсонизм,-С.Пб., 1995,-215с.
- Кандель Э.И. Джеймс Паркинсон и современные проблемы паркинсонизма//Журн. невропатол. и психиатр.- 1975.-№ 11.-С. 1721−1725.
- Кандель Э.И. Паркинсонизм и его хирургическое лечение,— М.:Медицина, 1965.-383 с.
- Коновалов Н.В. Гепатолентикулярная дегенерация (псевдосклероз, болезнь Вильсона). Печень и мозг. М.: Медгиз, 1948.
- Коновалов Н.В. Гепатоцеребральная дистрофия. М., 1960. 556 с.
- Корсакова Н.К., Московичюте Л. И. Подкорковые структуры мозга и психические процессы. М.: МГУ, 1985, — 134 с.
- Крыжановский Г. Н. Детерминантные структуры в патологии нервной системы. М.:Медицина, 1980. -360С.
- Крыжановский Г. Н. Общая патофизиология нервной системы.М.:Медицина, 1997. -351С.
- Крыжановский Г. Н., Карабань И. Н., Магаева С. В., Карабань Н. В. Компенсаторные и восстановительные процессы при паркинсоизме.- Киев, 1995.-186 с.
- Курганский A.B. Механизмы центрального программирования произвольных серийных движений и их формирование в онтогенезе.//Автореф. канд. диссерт. М., 1994.
- Курганский A.B., Подлепа A.C. Зависимость временных характеристик ритмических движений от их структурной сложности.//Вест. Моск. Ун-та.Сер. 14.Психология. 1998.
- Левин Г. З. Спорные вопросы основных форм паркинсонизма//Клин.мед, — 1977.-№ 9.- С. 8489.
- Левин С.Л. Дофаминергическая концепция паркинсонизма и лечение его Ь-ДОФА//Журн. невропатол. и психиатр.- 1972.-№ 9,-С.1418−1426.
- Левин Я.И. Патология церебральных дофаминергических систем (неврологические и нейроэндокринологическне аспекты)//Дис. докт. мед. наук.-М., 1991.
- Лурия А.Р. Высшие корковые функции человека. М., МГУ, 1969- 506 с.
- Лурия А.Р. Нейропсихология памяти (нарушения памяти при локальных поражениях мозга)//М., Педагогика, 1974 С. 312.
- Лурия А.Р. Основы нейропсихология. М, МГУ, 1973. 378 с.
- Мозолевский Ю.В., Яхно H.H., Вознесенская Т. Г. и соавт. Прогрессирующий надъядерный паралич.//Журн.невропат, и психиатр., 1980. -№ 3. -С.67−72. .
- Панасюк А.Ю. Адаптированный вариант метолики Д.Векслера. М. НИИ психиатрии МЗ РФб 1973.-79 С.
- Петелин Л.С. Актуальные вопросы паркинсонизма (лекция)//М., 1985.
- Петелин Л.С., Атаджданов М. Генетика болезни Паркинсона.-Ташкент: Медицина, 1977.-С. 102.
- Петелин Л.С., Шток В. Н., Пигарев В. А. Лечение паркинсонизма: методические рекомендации. М., 1980. — 59 с.
- Попелянский Я.Ю. Сравнительная клиническая характеристика дрожательного паралича и постэнцефалитического паркинсонизма//Автореф. дис.. канд. мед.наук.- М., 1949.
- Пятницкий Н.Н., Павлюченко Е. М., Михеев В. В. Патофизиология и патологическая анатомия постэнцефалитического паркинсонизма//Совр. психоневрол.- 1927.-№ 5.- С. 438−444.
- Розе Н.А. Психомоторика взрослого человека.- Л. ЛГУ, 1970.
- Садеков Р.К. Вызванные потенциалы при паркинсонизме//Неврол. журн.-1997, — № 4.- С.64−65.
- Садеков Р.К. Вегетативные нарушения при болезни Паркинсона//Неврол. журн.- 1996.-№ 3,-С.104−105.
- Садикова О.Н. Корреляция клинических, нейропсихологических и ком-пьютерно-томографических данных при болезни Паркинсона//Автореф.дис. канд.мед.наук-М., 1997.
- Садикова О.Н., Глозман Ж. М. Компьютерно-томографические корреляты когнитивных расстройств при болезни Паркинсона//Неврол. журн.- 1997.- № 10.-С. 40−44.
- Смоленцева И.Г. Влияние агонистов дофаминовых рецепторов на двигательные и нейропсихологические расстройства у больных с болезнью Паркинсона. Дисс. качд мед н., М., 2000.
- Столярова Л.Г., Кадыков А. С., Кистенёв Б. А. и др. Реабилитация больных паркинсонизмом. -М&bdquo- Медицина, 1979.-168 с.
- Федорова Н.В. Лечение и реабилитация больных паркинсонизмом.//Автореф.дис. докт.мед.наук.-М., 1996.
- Фёдорова Н.В., Шток В. Н. Этиологическая структура паркинсонизма и клинический патоморфоз при длительном лечении. // Вестник практической неврологии. 1995. — № 1.-е. 87−88.
- Хатиашвили И.Т., Яхно Н. Н. Клиническая оценка глазодвигательных нарушений при паркинсонизме.//Неврологический журнал, 2000, — Т.5 -С.27−31.
- Хуторская О. Е. Индивидуальный подбор фармакотерапии при паркинсонизме с помощью компьютерной диагностики//Ж. Невропатология и психиатрия им. С. С. Корсакова.1М12 1998 С. 25−28.
- Шток В.Н., Федорова Н. В. Лечение паркинсонизма//М., 1997.-С. 196.
- Штульман Д.Р., Нодель М. Р., Лавров А. Ю. и соавт. Случай гипоксически-ишемической энцефалопатии с акинетико-ригидным синдромом и дистонией //Неврологический журнал, 2000.-№ 3. -С.34−38.
- Яхно Н.Н. Актуальные вопросы нейрогериатрии//В кн.: Достижения в нейрогериатрии. М., 1995.-С.9−27.
- Яхно Н.Н. Современные подходы к лекарственному лечению болезни Паркинсона//Клиническая фармокология и терапия, 1994,-№ 3−4.-С.92−97.
- Яхно Н.Н., Дамулин И. В., Гончаров О. А. Сравнительная оценка различных форм паркинсонизма у больных пожилого и старческого возраста.// Журн. невролог, и психиатр, им. С. С. Корсакова, 1992. -Т.92. N1. -С. 67−72.
- Яхно Н.Н., Захаров В. В., Елкин М. Н. Прогрессирующий надъядерный паралич. // Неврологический журнал, 1997. -№ 6. -С.13−17.
- Яхно Н.Н., Павлова А. И., Роговина Е. Г. Ювенильный паркинсонизм.//Неврологический журнал, 1996. -№ 2. С. 29−33.
- Яхно Н.Н., Штульман Д. Р., Мельничук П. В. Паркинсонизм//Болезни нервной системы.-М., 1995.-Т. 2.-С. 144−159.
- Aarsland D, Andersen К, Larsen JP, et al. Risk of dementia in Parkinson’s disease: a community-based, prospective study.// Neurology, 2001.-V.56.-P.730−736.
- Aarsland D, Ballard C, McKeith I, et al. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson’s disease.// J. Neuropsychiatry Clin. Neurosci, 2001.-V.13.-P.374−379.
- Aarsland D, Larsen JP, Cummings JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.// Arch. Neurol., 1999.-V.56.-P.595−601.
- Aarsland D, Litvan I, Larsen JP. Neuropsychiatry symptoms of patients with progressive supranuclear palsy and Parkinson’s disease.// J. Neuropsychiatry Clin. Neurosci, 2001.-V.13.-P.42−49.
- Aarsland D., Larsen J.P., Lim N.G. et al. Range of neuropsychiatric disturbances in patients with Parkinson’s disease.// J.Neurol., 1999. -V.67. -P.492−496.
- Achiron A., Ziv I., Goren M., et al. Primary progressive freezing gait.// Mov. Disord., 1993. V.8. — P.293−297.
- Adams CW, Bruton CJ. The cerebral vasculature in dementia pugilistica.// J. Neurol. Neurosurg. Psychiatry, 1989.-V.52.-P.600−604.
- Adams JH, Mitchell DE, Graham DI, et al. Diffuse brain damage of immediate impact type. Its relationship to primary brain-stem damage in head injury. //Brain, 1977.-V.100.-P.489−502.
- Adams RD, Fisher CM, Hakim S, et al. Symptomatic occult hydrocephalus with 'normal' cerebrospinal fluid pressure: a treatable syndrome.// N. Engl. J. Med., 1965.-V.273.-P.117−126.
- Adler C.H., Stern M.B., Brooks M.L. Parkinsonism secondary to bilateral striatal fungal abscesses. //Mov. Disord., 1989. -V.4. -P.333−337.
- AFifi A.K., Bergman R.A. Functional neuroanatomy. //New York, McGraw-Hill, 1998. -730 P.
- Agid Y, Javoy-Agid F, Ruberg M, et al. Progressive supranuclear palsy: anatomo-clinical and biochemical considerations. //Adv. Neurol., 1986.-V.45.-P.191−206.
- Albert M.S., Feldman R.G., Willis A.L. The subcortical dementia of progressive supranuclear palsy // J. Neurol. Neurosurg. Psychiatry, 1974. -V.37. -P. 121−130.
- Albin RL, Y^ung AB, Penney JB. The functional anatomy of basal ganglia disorders.//Trends Neurol. Sei, 1989, — V.12.-P.366−375.
- M.Alexander G.A., DeLong M.R. Central mechanism of initiation and control of movement //In: A.K.Asbury, G.M.McIChann, W.I.McDonald (eds). Diseases of Nervous System. Clinical Neurobiology, 2ed. Philadelphia, WB Saunders, 1992. -P.285−308.
- Alexander G.A., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex//Ann.Rev.Neurosci., 1986. -V.9. -P.357−381.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, (DSM IV).// Washington, DC: American Psychiatric Association, 1994.
- Antonini A., Leenders K.L., Vontobel P. et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple atrophy and Parkinson’s disease // Brain, 1997. -V.120. -P.2187 -2192
- Aotsuka A., Shinotoh H., Hirayama K. et al. MRI in Parkinson’s disease and vascular parkinsonism//Rinsho Shinkeigaku, 1991. -V.31. P.619−624.
- Arai T, Ikeda K. Phenotypic heterogeneity of FTDP-17: implications for the differences of pathological phenotype among sporadic tauopathies.// Neurobiol. Aging, 2001.-V.22.-P.127−129.
- Armstrong RA, Lantos PL, Cairns NJ. The spatial patterns of pathological brain lesions in 12 patients with corticobasal degeneration// Pathophysiology, 2001.-V.l.-P.47−53.
- Arvanitakis Z, Wszolek ZK. Recent advances in the understanding of tau protein and movement disorders.// Curr. Opin. Neurol., 2001.-V.14.-P.491−497.
- Asahina M., Suhara T., Shinotoh H. et al. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson’s disease: a positron emission tomographic study. // J.Neurol. Neurosurg. Psychiatry, 1998. -V.65. -P.155−163.
- Atchison P.R., Thompson P.D., Frackowiak R.S., Marsden C.D. The syndrome of gait ignition failure: a report of six cases.// Mov. Disord., 1993. V.8. — P.285−292.
- Averbuch-Heller L., Paulson G.W., Daroff R.B. et al. Whipple’s disease mimicking progressive supranuclear palsy.// J. Neurol. Neurosurg. Psychiatry, 1999. -V.66. -P.532−535.
- Ay H, Buonanno FS, Price BH, et al. Sensory alien hand syndrome: case report and review of the literature.// J. Neurol. Neurosurg. Psychiatry, 1998.-V.65.-P.366−369.
- Bak TH, Hodges JR. The neuropsychology of progressive supranuclear palsy.// Neurocase, 1998.-V.-P.489−494.
- Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy.// Hum. Mol. Genet., 1999.-V.8.-P.711−715.
- Ballan G., Yekhlef F., Macia F. et al. Routine MRI in multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration: differential diagnosis clues with Parkinson’s disease// Mov.disord., 2000. -V.15(suppl.3)-P.205.
- Baloh RW, Vinters HV. White matter lesions and disequilibrium in older people. I. Case control comparison. //Arch. Neurol., 1995.-V.52.-P.970−974.
- Barber R., Gholkar A., Scheltens P. et al. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies //Neurology, 1999. -V.52. -P.l 153−1158.
- Barclay C.L., Lang A. Dystonia in progressive supranuclear palsy. // J.Neurol. Neurosurg. Psychiatry, 1997. -V.62. -P.352−356.
- Beck A. T. Ward C. H., Mendelson M. et al. An inventory for measuring depression.//Arch Gen Psychiat. -1961, — № 4. P. 561−571.
- Benamer H.T.S., Patterson J., Hadley D.M. et al. Dopaminergic dysfunction in vascular parkinsonism: a 123I-FP-CIT SPECT study.//Mov.disord" 2000(S.3)-P.210.
- Berardelli A, Rothwell JC, Thompson PD, et al. Pathophysiology of bradykinesia in Parkinson’s disease// Brain, 2001. V. 124. — P.2131 -2146.
- Berg D., Naumann M., Hoggenmuller U. Et al. Differences of echogenicity and T2 relaxation time of the nucleus lenticularis in MSA and PNP as compared to Parkinson’s disease// Mov.disord., 2000. -V.15(suppl.3)-P.206.
- Bhatia K.P., Lee M.S., Rinne J.O. et al. Corticobasal degeneration look-alikes// In: I. Litva, C.G.Goetz, A.E.Lang (eds.) Corticobasal degeneration and related disorders. Adv.Neurol., V j2. -Philadelphia, 2000.-P.169−182.
- Bhatia K.P., Rothwell J., Brown R. et al. Parkinsonism following isolated bilateral g' /bus pallidus lesions. // Mov. Disord., 1994. V.9, suppl.l.-P.lOl.
- Bhatt M.H., Obeso J.A., Marsden C.D. Time course of postanoxic akinetic-rigid and dystonic syndromes //Neurology, 1993. -V.43. -P.314−317.
- Bigio EH, Brown DF, White CL. Progressive supranuclear palsy with dementia: cortical pathology. //J. Neuropathol. Exp. Neurol., 1999.-V. 58.-P.359−364.
- Bird T.D. Genotypes, phenotypes, and frontotemporal dementia: take your pick.//Neurology, 1998. -V.50. -P. 1526−1527.
- Bird TD, Nochlin D, Poorkaj P, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L).// Brain, 1999.-V.-122.-P.741−756.
- Birdi S., Nomani., Fenton M. et al. PSP clinical diagnosis -problems and confounding factors.// Mov.disord., 2000-V. 15. (Supl.3). -P.230.
- SO.Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.// Arch. Neurol., 1990.-V.47.-P.747−752.
- Blin J, Vidailhet M, Pillon B, et al. Corticobasal degeneration: decreased and asymmetric glucose consumption as studied with PET. //Mov. Disord., 1992.-V.7.-P.348−354.
- Block SA, Bakshi R. FLAIR MRI of striatonigral degeneration.// Neurology, 2001.-V.56.-P. 1200.
- Bodensteiner JB, Schaefer GB. Dementia pugilistica and cavum septi pellucidi: born to box? //Sports Med., 1997.-V.24.-P.361−365.
- Boecker H., Weindl A., Leenders K., et al. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with 18 °F.FDG and [18F]fluorodopa.//Acta. Neurol. Scand., 1996. -V.93. -P.387−392.
- Boeve B Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. //Neurology, 1999.-V.53.-P.795−800.
- Boeve B.F., Maragonore D.M., Parisi J.E. et al. Disorders mimicking the «classical» clinical syndrome of cortico-basal ganglionic degeneration//Mov. Disord., 1996. -V.l 1 -P.347−351.
- Bogdanoff B, Natter HM. Incidence of cavum septum pellucidum in adults: a sign of boxer’s encephalopathy.// Neurology, 1989.-V.39.-P.991−992.
- Boghen D. Apraxiaoflid opening. //Neurology, 1997. -V.48. -P.1491−1503.
- Boon AJ, Tans JT, Deiwel EJ, et al. Dutch normal-pressure hydrocephalus study: the role of cerebrovascular disease.//J. Neurosurg., 1999.-V.90.-P.221−226.
- Bradley WG, Scalzo D, Queralt J, et al. Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MRI imaging. //Radiology, 1996.-V. 198.-P.523−529.
- Bradshaw J.L., Mattingley J.B. Clinical Neuropsychology. //Behavioral and Brain Science. San Diego, Academic Press, 1995. -^458 P.
- Brooks D.J. Functional imaging of movement disorders // In: C.D.Marsden, S. Fahn (eds). Movement disorders 3. Cambrridge, Butterworth Heinemann, 1994. -P.46−64.
- Brooks D.J. The early diagnosis of Parkinson’s disease//Ann Neurol 1998−44(Suppl 1):S10-S18.
- Brooks DJ, Playford ED, Ibanez V, et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. //Neurology, 1992.-V.42.-P.1554−1560.
- Brotchie P., Iansek R., Home M.K. Motor function of the monkey globus pallidus//Brain, 1991. -V.114. -P.1667−1683.
- Brown P. Oscillatory nature of human basal ganglia activity: a relationship to the pathophysiology of Parkinson’s disease.//Mov.disord., 2003. -V.18. -P.357−363.
- Brown R.G., Marsden C.D. Neuropsychology and cognitive function in Parkinson’s disease // C.D.Marsden, S.Fahn. Movement disorders 2. Cambrridge, Butterworth Heinemann, 1987. -P.99−123.
- Brunt ER, van Weerden TW, Pruim J, et al. Unique myoclonic pattern in corticobasal degeneration. //Mov. Disord., 1995.-V.10(2).-P.132−142.
- Buchman A.S., Goetz C.G., Klawans H.L. Hemiparkinsoni m with hemiatrophy. //A/euro/ogy, 1988.-V.38.-P. 527−530.
- Buee-Scherrer V, Buee L, Leveugle B, et al. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer’s disease and other neurodegenerative disorders.// Ann. Neurol., 1997, — V.42.-P.356−359.
- Burk K, Skalej M, Dichgans J. Pontine MRI hyperintensities (the Cross Sign) are not pathognomonic of multiple system atrophy. //Mov. Dis., 2001.-V.16.-P.535−536.
- Burn D.J., Brooks D.J. Nigral dysfunction in drug-induced parkinsonism//Neurology, 1993. -V.43. -P.552−556.
- Byrne E.J., Lennox G., Lowe J. et al. Diffuse Lewy bodies disease: clinical features in 15 cases.// J.Neurol. Neurosurg. Psychiatry, 1989. -V.52. -P.709−717.
- Caligiuri MP, Rockwell E, Jeste DV. Extrapyramidal side effects in patients with Alzheimer’s disease treated with low-dose neuroleptic medication. //Am. J. Geriatr. Psychiatry, 1998.-V.6.-P.75−82.
- Calne D.B., Chu N.S., Huang C.C. et al. Manganisi-, and idiopathic parkinsonism: similarities and differences //Neurology, 1994. -V.44. -P. 1583−1586.
- Caplan LR. Binswanger’s disease revisited. //Neurology, 1995.-V.45.-P. 626−633.
- Cardoso F, Camargos S. Juvenile parkinsonism: a heterogeneous study. //Eur. J. Neurol., 2000,-V.7.-P.467−471.
- Carella F., Ciano C., Panzica F. et al. Myoclonus in corticobasal degeneration //Mov.disord., 1997. -V.12. -P.598−603.
- Chabolla DR, Maraganore DM, Ahlskog JE, et al. Drug-induced parkinsonism as a risk factor for Parkinson’s disease: a historical cohort study in Olmsted County, Minnesota. //Mayo Clin. Proc., 1998,-V.73.-P.724−727.
- Chamorro A., Marshall R.S., Valls-Solu J., et al. Motor behavior in stroke patients with isolated medial frontal ischemic infarction.//Stroke, 1997. -V.28. -P. 1755.
- Chang C.M., Yu Y.L., Ng H.K., et al. Vascular pseudoparkinsonism.// Acta Neurol. Scand., 1992. V. 86. — P. 588−592.
- Chan-Palay V. Depression and dementia in Parkinson’s disease: catechlamine changes in the locus ceruleus, a basis for therapy//Adv. Neurol., 1993.-V.60.-P.438−446.
- Churchyard A, Lees AJ. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson’s disease.// Neurology 1997.-V.49.-P. 1570−1576.
- Callen A., Calopa M., Jauma S. et al. Parkinsonism as a manifestation of brain tumor // Mov.disord., 2000-V.15. (Supl.3). -P.234.
- Cardoso F., Jankovic J. Peripherally induced tremor and parkinsonism //Arch.Neurol., 1995. -V.52. -P.263−270.
- Carluer L., Marie R.M., Constans J.M. et al. Bilateral Symetrical hypoxic-ischemic injury of the putamen inducing a progressive and severe freezing // Mov.disord., 2000-V.15. (Supl.3). -P.232.
- Clarke CE, Davies P. Systemic review ol’acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson’s disease.// J. Neurol. Neurosurg. Psychiatry, 2000.-V.69.-P.590−594.
- Clarke CE. Does levodopa therapy delay death in Parkinson’s disease? A review of the evidence.// Mov. Disord., 1995.-V.10(No. 3).-P.250−256.
- Cohen S., Freedman M. Cognitive and behavioral changes in the parkinson-plus syndromes // Behavioral. Neurology of Movement Disorders / Eds W. J. Weiner, A. E. Lang. — New York, 1995. -P. 139−157.
- Collerton D., Davies C., Thompson P. Dementia with Lewy bodies in clinical practice.// In: R.H.Perry, I.G.McKeith, E.K.Perry (eds). Dementia with Lewy bodies. Cambridge University Press, 1996.-P. 171−186.
- Collins S.J., Ahsskog J.E., Parisi J.E. et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.// J.Neurol. Neurosurg. Psychiatry, 1995. -V.58. -P. 167−173.
- Colosimo C., Albanese A., Hughes A.J. et al. Some clinical features differentiate multiple system anrophy from Parkinson' disease // Arch. Neurol., 1995. -V.52. C. 295−298.
- Cooper J.A., Sagar H.J., Doherty S.M. et al. Different effects of dopaninergic and anticholinergic therapies on cognitive and motor function in Parkinson’s disease// Brain, 1992. -V.l 15. -P.1701−1725.
- Cordata NJ, Halliday GM, McCann H, et al. Corticobasal syndrome with tau pathology. //Mov. Disord., 2001.-V.l6.-P.656−667.
- Criuhley M. Arteriosclerotic parkinsonism.// Brain, 1929. V. 52. — P. 23−83.
- Cummings J.L. Subcortical dementia: neuropsychology, neuropsychiatry, pathophysiology //Br.J.Psychiatry, 1986. -V.149. -P.682 -697.
- Cummings J.L. Depression in Parkinson’s disease.//Am. J. Psychiatry, 1992.-V. 149.-P.443−454.
- Cummings JL. Frontal-subcortical circuits and human behavior.// Arch. Neurol., 1993.-V.50,-P.873−880.
- Cummings J.L. Anatomic and behavioral aspects of frontal-subcortical circuits //Annals New York Academy of Sciences, 1995. -V.769.-P.1−13.
- Cummings J.L. Cholinesterase inhibitors: a new class of psychotropic compounds. //Am.J.Psychiatry, 2000. -V.l57. -P.4−15.
- Currie LJ, Bennett JP, Harison MB, Trugman JM, Wooten GF. Clinical correlates of sleep benefit in Parkinson’s disease. //Neurology, 1997.-P.1115−1117.
- Dagher A. Functional imaging in Parkinson’s disease. //Semin. Neurol., 2001.-V.21.-P.23−32.
- Daniel S.E., de Bruin V.M.S., Lees A.J. The clinical and pathological spectrum of Steel-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. //Brain, 1995. -V.l 18. -P.759−770.
- Daniele A, Moro E, Bentivoglio AR. Zolpidem in progressive supranuclear palsy. N Engl J Med 1999−341:543−4.
- Davie CA, Barker, GJ, Machado C, Miller DH, Lees AJ. Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome.// Mov. Disord., 1997.-V. 12.-P.767−771.
- Davis PH, Golbe LI, Duvoisin RC, Schoenberg BS. Risk factors for progressive supranuclear palsy.//Neurology, 1988.-V.38.-P. 1546−1552.
- Defebvre L., Lecouffe P., Destee A. et al. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson’s disease.// Acta Neurol. Scand., 1995. V.92. -P.235−241.
- DeLong M.R. Primate models of movement disorders of basal ganglia origin.//Trends Neurol. Sci, 1990.-V.13.-P.281−289.
- Dejerine J, Thomas A. L’atrophie olivopontocerebelleuse.// Nouv. Iconogr. Salpet., 1900.-V.13,-P.330−370.
- Del Ser T., Munoz D.G., H-.ohinski V. Temporal pattern of cognitive decline and incontonence is different in Alzheimer’s disease and diffuse Lewy body disease//Neurology, 1996. -V.46. -P.682−686.
- Delwaide P.J., Gonce M. Pathophysiology of parkinsonian signs//In: J. Jankovic, E. Tolosa (eds). Parkinson’s disease and movement disorders. 3nd ed. Baltimore. Williams&Wilkins, 1998. -P. 159 175.
- Denes G. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. //Neurology, 2002.-V.58.-P. 1317.
- Denny-Brown D. Disease of the basal ganglia and subthalamic nuclei. //Oxford University Press. New York, 1946.-302 P.
- Denny-Brown D. The nature of apraxia.// J. Nerv. Ment. Dis., 1958.-V.216.-P.9−32.
- Deuschl G., Bain P., Brin M. and Ad Hoc Scientific Committee. Consensus statement of the movement disorder society on tremor// Mov.disord., 1998. -V.13.(Supl.3). -PP. 2−23.
- Dickson DW, Liu WK, Hardy J, et ai. Widespread alterations in alpha-synuclein in multiple system atrophy. //Am. J. Pathol., 1999.-V. 155.-P. 1241−1251.
- Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.//J. Neurol., 1999.-V.246(Suppl 2):II.-P.6−15.
- Doody R. S., Jankovic J. The alien hand and related signs // J. Neurol. Neurosurg. Psychiatr. — 1992. — Vol. 55. — P. 806— 810.
- Dose M. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.// Pharmacopsychiatry, 2000.-V.33.-P.3−13.
- Doty R.L., Golbe L.I., McKeown D.A., et al. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson’s disease.//Neurology, 1993.-V.43.-P.962−965.
- Dubinsky R.M., Jankovic J. Progressive supranuclear palsy and a multi-infarct state. //Neurology, 1987. -V.37. -P.570−576.
- Dubois B, Slachevsky A, Litvan I, et al. The FAB. A frontal assessment battery at bedside. //Neurology, 2000.-V.55.-P. 1621 -1626.
- Dubois B., Danze F., Pillon B., et al. Cholincrgic-dependent cognitive deficits in Parkinson’s disease.//Ann. Neural., 1987.-V.22.-P.26−30.
- Dubois B., Pillon B. Cognitive and behavioral aspects of movement disorders // In: J. Jankovic, E. Tolosa (eds). Parkinson’s disease and movement disorders. 3nd ed. Baltimore. Williams^Wilkins, 1998.-P.837−858.
- Dubois B., Pillon B., Legault F et al. Slowing of cognitive processing in progressive supranuclear palsy: a comparison with Parkinson’s disease //Arch Neurol., 1988. -V.45. -P.l 194−1199.
- Dubois B., Pillon B., Sternic N. Age-induced cognitive disturbances in Parkinson’s disease.//Neurology, 1990.-V.40.-P.38−41.
- Dujardin K, Defebvre L, Grunberg C, et al. Memory and executive function in sporadic and familial Parkinson’s disease.// Brain, 2001.-V.124.-P.389−398.
- Durif F, Pollak P, Hommel M, et al. Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson’s disease. VEur. Neurol., 1992.-V.32.-P. 32−36.
- Earnst MP, Fahn S, Kaip JH, et al. Normal pressure hydrocephalus and hypertensive cerebrovascular disease.// Arch. Neurol., 1974.-V. 31.-P.262−266.
- Ebersbach G, Sojer M, Valldeoriola F, et al. Comparative analysis of gait in Parkinson’s disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy.// Brain, 1999.-V.122.-P. 1349−1355.
- Ebmeier K.P., Calder S.A., Crawford J.R., et al. Clinical features predicting dementia in idiopathic Parkinson’s disease: a follow up study//Neurology, 1990.-V.40.P.1222−1224.
- Ehringer H, Hornykiewicz O. Verteilung van noradrenalen und dopamine (3-hydroxytyramine) im gehirn des menschen und ihr berhatten bei erkrankingen des extrapyramidalen systems.// Klin. Wochenschr., 1960.-V.24.-P.1236−1239.
- Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism.// J. Cereb. Blood. Flow Mctab., 1994.-V.14.-P.783−801.
- Eidelberg D. Differential diagnosis of parkinsonism with 18 °F.-fluorodeoxyglucose (FDG) and PET. //Mov. Disord., 1996.-V.11.-P.349.
- Eisensehr I, Lindeiner H, Jager M, et al. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson’s disease: is there a need for polysomnography?// J. Neurol. Sei., 2001,-V.186.-P.7−11.
- Elbaz A, Bower JH, Maraganore DM, et al. Risk tables for parkinsonism and Parkinson’s disease.// J. Clin. Epidemiol., 2002.-V.55.-P.25−31.
- Elble R.J. Gait disorders: pathophysiology of standing and locomotion.// Mov.Disord., 1998. -V.13 (S2). P.9−10.Elbe R.J., Hudges L" Higgins C. The syndrome of senile gait.//J.Neurol., 1992. -V.239. -P.71−75.
- Elble R.J., Moody C., Leffler K., et al. The initiation of normal walking.// Mov. disord., 1994. -V.9.-P. 139−146.
- Elble R.J., Cousins R., Leffler K., et al. Gait initiation by patients with lower-half parkinsonism. // Brain, 1996. V. l 19. — P. 1705−1716.
- Elias JW, Treland JE. Executive function in Parkinson’s disease and subcortical disorders// Sem. Clin. Neuropsychiat., 1999.-V.4.-P.34−40.
- Ellie E., Julien J., Ferrer X. Familial idiopathic striopallidodentate calcifications.// Neurology, 1989. -V.39. -P.381−385.
- Ellis RJ, Caligiuri M, Galasko D, et al. Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. //Alzheimer Dis. Assoc. Disord., 1996.-V.10.-P. 103−114.
- Fahn S., Elton R. Unified Parkinson’s disease rating scale. Recent developments in Parkinson’s disease. // Fahn S., Marsden C., Calne D. et al. (Eds). McMillan Healthcare Information. V. 5. — 1987 -P. 153−163.
- Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities.//Neurology, 1993.-V.43.-P. 1683−1689.
- Ft any MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration.// J. Neuropathol. Exp. Neurol., 1996.-V.55.-P.53−67.
- Fearnley J.M., Lees A.J. Ageing and Parkinson’s disease: substantia nigra regional selectivity.//Brain, 1991 .-V. 14.-P.2283—2301.
- Feifel D. Neurotransmitters and neuromodulators in frontal-subcortical circuits.// In: Miller BL, Cummings JL, editors. The human frontal lobes. New York: The Guilford Press, 1999.-P. 174−186.
- Fell J.M., Reynolds A.P., Meadows N. et al. Manganese toxicity in children receiving long-term parenteral nutrition//Lancet, 1996. -V.347. -PI218−1221.
- Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson’s disease. Prevalence, phenomenology and risk factors.// Brain, 2000.-V.123.-P.733−745.
- Fenelon G., Gray F., Wallays C. et al. Parkinsonism and dilatation of the perivascular spaces (etat crible) of the striatum.// Mov. Disord., 1995. V. l 0. — P. 754−760.
- Fentoni V., Soliveri P., Monza D. et al. Affective symptoms in multiple system atrophy and Parkinson’s disease: responces to levodopa therapy // J Neurcl. Neurosurg. Psychiatry, 1999. -V.66. -P. 541−544.
- Fernandez HH, Friedman JH, Jacques C, et al. Quetiapine for the treatment of drug-induced psychosis in Parkinson’s disease.// Mov. Disord., 1999.-V.14.-P.484−487.
- Fernandez R.F. Thalamic lacune and contralateral hemiparkinsonism subsequently relieved by spontaneous thalamo-subthalamic hematoma // Mov. disord., 1995. V.10. — P.116 -117.
- Filley C.M. Neuropsychiatric features of Lewy body disease //Brain Cogn., 1995. -V.28. -P.229−239.
- Fisher CM. Hydrocephalus as a cause of disturbances of gait in the elderly.// Neurology, 1982.-V.32.-P.1358−1363.
- FitzGerald P.M., Jankovic J. Lower body parkinsonism: evidence for vascular etiology.// Mov.Disord., 1989. V.4. — P. 249−260.
- Foti D.J., Cummings J.L. Neurobehavioral aspects of movement disorders // In: R.L.Watts, W.C.Koller (eds). Movement disorders. New York McGraw-Hill, 1997. -P. 15−30.
- Frattali CM, Grafman J, Patronas N, et al. Language disturbances in corticobasal degeneration.// Neurology, 2000.-V.54.-P.990−992.
- Freidman D.I., Jankovic J., McCrary J.A. Neuro-ophtalmic findings in progressive supranuclear palsy. //J. Clinical Neuro-ophtalmology, 1992. -V.12(2). -P.104−109.
- Friedman JH, Factor SA. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson’s disease.// Mov. Disord., 2000.-V.15.-P.201−211.
- Friedman JH, Friedman H. Fatigue in Parkinson’s disease: a nine-year follow-up. //Mov. Disord., 2001.-V.16.-P.1120−1122.
- Frucht S, Fahn S, Chin S, et al. Levodopa-induced dyskinesias in autopsy-proven cortical basal ganglionic degeneration. //Mov. Disord., 2000.-V. 15.-P.340−343.
- Fuente-Fernandez R., Calne D.B. What do Lewy bodies tell us about dementia and parkinsonism 1996 //In: R.H.Perry, I.G.McKeith, E.K.Perry (eds). Dementia with Lewy bodies. Cambridge University Press, 1996. P.287−301.
- Gai WP, Power JH, Blumbergs PC, et al. Multiple-system atrophy: a new alpha-synuclein disease?// Lancet, 1998.-V.352.-P.547−548.
- Galasko D, Katzman R, Salmon DP. Clinical and neuropathological findings in Lewy body dementia.// Brain Cogn., 1996.-V.31.-V.176−185.
- Gallassi R, Morreale A, Montagna P, et al. Binswanger’s disease and normal-pressure hydrocephalus: clinical and neuropsychological comparison.// Arch. Neurol., 1991.-V.48.-P. 11 561 159.
- Gallien P, Verin M, Rancurel G, et al. First familial cases of corticobasal degeneration. //Neurology, 19O8.-V.50.-P.A428.
- Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications.// Arch. Neurol., 2001 .-V.58.-P. 186−190.
- Gascon J., Calopa M., Ois A. et al. Long lasting parkinsonism as initial clinical feature of dementia with Lewy bodies //Mov.disord., 2000. -V.15(Suppl.3). -P.229.
- Gearing M., Olson D.A., Watts R.L., et al. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. //Neurology, 1994. -V.44. -P.1015−1024.
- Geddes JF, Vowles GH, Nicoll JA, et al. Neuronal cytoskeletal changes are an earl ¦ consequence of repetitive head injury. //Acta Neuropathol., 1999.-V.98.-P.171−178.
- Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. //Arch. Neurol., 1999.-V.56.-P.33−39.
- Geschwind D.H., Loginov M., Stern J.M. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease).// Am. J. Hum. Genet., 1999. -V.65. -P. 764−772.
- Gerschlager W., Bencsits G., Pirker W., et al. 123I. beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson’s disease.//Mov. Disord., 2002. -V.17. -P. 518−523.
- Ghika J., Bogousslavsky J. Abnormal movements.//In:J.Bogousslavsky, L. Caplan (eds) Stroke syndromes. Cambridge University Press, 1996. -P. 91−101.
- Ghika J., Bogousslavsky J. Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. //Arch.Neurol., 1997. -V.54. -P.l 104−1108.
- Gibb W.R.G., Narabayashi H., Yokoshi M. et al. New pathologic observations in juvenile onset parkinsonism with dystonia. // Neurology, 1991. -V.41. -P.820−822.
- Gibb WRG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). //Brain, 1985.-V.110.-P.1131−1153.
- Giladi N. Freezing of gait. Clinical review. //Adv. Neurol., 2001.-V. 87.-P.191−197.
- Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD. Prospective assessment of the DATATOP cohort.// Neurology, 2001.-V.56.-P.1712−1721.
- Giladi N, McMahon D, Przedborski S, et al. Motor blocks in Parkinson’s disease.// Neurology, 1992.-V.42.-P.333−339.
- Giladi N, Simon ES, Korczyn AD, et al. Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson’s disease.// Muscle Nerve, 2000.-V.23.-P.731−734.
- Giladi N., Burke R.E., Costic V. et al. Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features.// Neurology, 1990.-V.40.-P. 1731−1734.
- Gilman S. Multiple system atrophy// In: J. Jankovic, E. Tolosa (eds). Parkinson’s disease and movement disorders. 3nd ed. Baltimore. Williams&Wilkins, 1998. -P.245−262.
- Gilman S., Quinn N.P. The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and others forms of idiopathic late-onset cerebellar atrophy //Neurology, 1996. -V.46. -P.l 197−1199.
- Gimenez-Roldan S, Mateo D, Benito C, et al. Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques.// J. Neural. Transm., 1994.-V.42.-P.79−90.
- Glatt S.L., Koller W.C. Effect of antiparkinsonian drugs on memory. In: Parkinson's disease. Neurobehavioral aspects. Eds Huber S.J., Cummings J.L.//New York-Oxford. Oxford University Press, 1992, P.303−312.
- Gnanalingham K.K., Byrne E.J., Thornton A. et al. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s diseases // J. Neurol. Neurosurg. Psychiatry, 1997, -V.62. -P.243−252.
- Goedert M, Spillantini MG, Crowther RA, et al. Tau gene mutation in familial progressive subcortical gliosis. //Nat. Med., 1999.-V.5.-P.454−457.
- Goetz C. Hallucinations in Parkinson’s disease.// In: G.M.Stern (ed.).Parkinson's disease. Adv. Neurol., 1999. -V.80. -P.419−424.
- Goetz CG, Blasucci LM, Leurgans S, et al. Olanzapine and Clozapine: comparative effects on motor function in hallucinating Parkinson’s disease patients// Neurology, 2000a.-V.55.-P.l-6.
- Goetz CG, Kompoliti A, Greene PE, et al. Pharmacological therapy in cortical-basal ganglionic degeneration.// Mov. Disord., 1996.-V.11.-P.350.
- Goetz CG, Leurgans S, Pappert EJ, et al. Prospective longitudinal assessment of hallucinations in Parkinson’s disease// Neurology, 2001c.-V.57.-P.2078−2082.
- Goetz CG, Pappert EJ, Blasucci LM, et al. Intravenous levodopa in hallucinating Parkinson’s disease patients: high-dose challenge does not precipitate hallucinations. //Neurology, 1998.-V.50.-P.515−517.
- Golbe L.I. Progressive supranuclear palsy. //In Watts R., Koller W., eds. Movement Disorders. McGraw-Hill, 1997 -P.279−296.
- Golbe L.I. Epidemiology of movement disorders // In: J. Jankovic, E. Tolosa (eds). Parkinson’s disease and movement disorders. 3nd ed. Baltimore. Williams&Wilkins, 1998. -P. 119−132.
- Golbe LI. Progressive supranuclear palsy. //In: Differential diagnosis and treatment of movement disorders. Tolosa E, Koller WC, Gershanik OS, editors. Butterworth Heinemann, Boston, 1998.-P.27−38.
- Golbe LI. Alpha-synuclein and Parkinson’s disease.// Mov. Disord., 1999.-V.14.-P.6−9.
- Golbe L.I., Davis P.H., Schoenberg B.S. et al. Prevalence and natural history of progressive supranuclear palsy. //Neurology, 1988. -V.38.-P.1031−1034.
- Golbe L.I., Rubin R.S., Cody R.P. et al. Follow-up study of risk factors in progressive supranuclear palsy. //Neurology, 1996. -V.47. -P.148−154.
- Golbe LI, Davis PH, Lepore FE. Eyelid movement abnormalities in progressive supranuclear palsy.//Mov. Disord., 1989.-V.4.-P.297−302.
- Goldberg G. When aliens invade: multiple mechanisms for dissociation between will and action// J. Neurol. Neurosurg. Psychiatr. 2000. — Vol. 68. — P. 68.
- Gotham A.M., Brown R.G., Marsden C.D. Frontal cognitive function in patients with Parkinson’s disease on and off levodopa .//Brain, 1988. -V. 111. -P.299−321.
- Goto S., Kunitoku N., Soyama N. et al. Posteroventral pallidotomy in a patient with parkinsonism caused by hypoxic encephalopathy //Neurology, 1997. -V.49. -P.707−710.
- Goto S., Matsumoto S., Ushio Y. et al. Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration // Neurology, 1996. -V.47. -P. 10 321 036.
- Gouider-Khouja N, Vidailhet M, Bonnet AM, et al. «Pure» striatonigral degeneration and Parkinson’s disease: a comparative clinical study.// Mov. Disord., 1995.-V. J 0.-P.288−294.
- Graff-Radford NR, Godersky JC. Idiopathic normal pressure hydrocephalus and systemic hypertension.// Neurology, 1987.-V.37.-P.868−871.
- Grafman J, Litvan I, Gomez C, et al. Frontal lobe function in progressive supranuclear palsy //Arch. Neurol., 1990.-V.47.-P.553−558.
- Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy.// Brain Cogn., 1995.-V.28.-P.311−320.
- Graham J.M., Paley M.N., Hogarth N. et al. Magnetic resonance imaging of brain iron deposition in patients with idiopathic Parkinson’s disease using the PRIME sequence //Mov.disord., 2000. -V.15(S.3)-206.
- Graham JG, Opperheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.// J. Neurol. Neurosurg. Psychiatry, 1969.-V.32.-P.28−34.
- Graybiel AM. The basal ganglia. //Curr. Biol., 2000.-V.10.-PR509−51 1.
- Grimes D.A., Lang A.E., Bergeron C.B. Dementia as the most common presentation of cortico-basal ganglionic degeneration.//Neurology, 1999. -V.53. -P.1969- 1973.
- Groenewegen H.J. Cortical-subcortical relationship and the limbic forebrain //In: M.R.Trimble, J.L.Cummings. Contemporary Behavioral Neurology, Boston, Butterworth Heinemann, 1997. -P29. -48.
- Grossman M, Carvel S., Goloomp S., et al. Sentence comprehension and praxis deficits in Parkinson’s disease//Neurology 1991.-V.41.-P.1620−1626.
- Haaxma R., van Boxel A., Brouwer W.H. et al. Motor function in a patient with bilateral lesions of the globus pallidus.// Mov. disord., 1995. V. 10. — P. 761−777.
- Habert MO, Smampinato U, Mas JL, et al. A comparative technetium 99m hexamethylpropylene amine oxime SPET sic. study in different types of dementia. //Eur. J. Nucl. Med., 1991.-V. 18.-P.3−11.
- Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics.// J. Neurol. Sci, 1965.-V.?.-P.307−327.
- Hallett M. Physiology of basal ganglia disorders: an overview//Can.J.Neurol.Sci, 1993. -V.20. -P.177−183.
- Hallett M. Plasticity and basal ganglia disorders//In Basal ganglia and thalamus in health and movement disorders. Moscow, 2000. P.24.
- Haniilton M. A rating scale for depression. //J.Neurol. Neurosurg Psychiatry, 1960. -V.23. -P.56−62.
- Hansen L, Samuel W. Criteria for Alzheimer disease and the nosology of dementia with Lewy bodies.// Neurology, 1997.-V.48.-P.126−132.
- Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson’s syndrome: clinical features and results of treatment with levodopa.// J. Neurol. Neurosurg. Psychiatry, 1988.-V.51.-P.850−854.
- Hargrave R, Rafal R. Depression in corticobasal degeneration. //Psychosomatics, 1998.-V.39,-P.481−482.
- Harrington M.G., Macpherson P., Mcintosh W.B. et al. The significance of the incidental finding of basal ganglia calcification on computad tomography.// J. Neurol. Neurosurg. Psychiatry, 1981. -V.44. -P.l 168−1170.
- Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of corticobasal degeneration. //J. Neuroimaging, 1996.-V. 6.-P. 222−226.
- Hauw J.-J., Daniel S.E., Dickson D. et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome. //Neurology, 1994. -V.44. -P.2015−2019.
- Heaton R.K. Wisconsin Card Sorting Test manual. Odessa, FL: Psychological Assessment Resources, 1981.
- Heilman K. M. The apraxia of cortico-basal ganglionic degeneration // Mov. Disord. — 1996. -Vol. 11.-P. 348.
- Heilmann K.M., Watson R.T., Valenstein E. Neglect and related disorders//In: K.M.Heilmann, E. Vallenstein (eds.). Clinical Neuropsychology, New York. Oxford University Press, 1993.-P.279−336.
- Heitanen M., Teravainen H. The effect of age of disease onset on neuropsychological performance in Parkinson’s disease.//J. Neurol. Neurosurg. Psychiatry, 1988.-V.51.-P.244−249.
- Hely M.A., Reid W.G., Halliday G.M. et al. Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer’s disease // J. Neurol. Neurosurg. Psychiatry, 1996. -V.60. -P.531
- Hietanen M., Teravainen H. Cognitive performance of patients with parkinsonism//Mov. Disord., 1996.-V.11.-P.515.
- Higgins JJ, Adler RL, Loveless JM. Mutational analysis of the tau gene in progressive supranuclear palsy.// Neurology, 1999.-V.53.-P.421−424.
- Hoehn M., Jahr M.D. Parkinsonism: onset, progression and mortality // Neurology. 1967. — V.17. — N5. — P.427−442.
- Hof PR, Bouras C, Buee L, et al. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer’s disease cases.// Acta Neuropathol. (Berl), 1992.-V.85,-P.23−30.
- Holmberg B, Rosengren L, Karlsson JE, et al. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson’s disease. //Mov. Disord., 1998.-V.13.-P.70−77.
- Holodni AI, Waxman R, George AE, et al. MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures.// AJNR Am. J. Neuroradiol., 1998.-V. 19.-P.813−819.
- Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson’s disease.// J. Neurol. Neurosurg. Psychiatry, 2001.-V.70.-P.734−738.
- Hoogendijk WJ, Sommer IE, Tissingh G, et al. Depression in Parkinson’s disease. The impact of symptom overlap on prevalence.//Psychosomatics, 1998.-V.39.-P.416−421.
- Homykiewicz O. Brain neurotransmitter changes in Parkinson’s disease. // Movement disorders, Neurology / Eds. C.D. Marsden, S. Fahn London: Butterworth Scientific, 1982. — V.2 — P. 41−58.
- Hornykiewicz O. Dopamine and Parkinson’s disease. A personal view of the past, the present, and the future. //Adv. Neurol., 2001 a.-V.86.-P. 1−11.
- Horoupian DS, Wasserstein PH. Alzheimer’s disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. //Acta Neuropathol. (Berl), 1999.-V.98.-P.317−322.
- Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.// Neurology, 2001.-V.56.-P.1702−1706.
- Huber S.J., Christy J.A., Paulson G.W. Cognitive heterogens associated with clinical subtypes of Parkinson’s disease.//Neuropsychol. Neuropsychiatry Behaw. Neurol.-199l.-Vol.4-P. 147−157.
- Huber S.J., Cummings J.L. (eds). Parkinson’s disease. Neurobehavioral aspects. //New York, Oxford, Oxford Univercity Press. 1992. — 368 P.
- Hughes A.J. Diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases //J.Neurol. Neurosurg. Psychiatry, 1992. V.55.- P. 181−184.
- Hughes A. J., Ben-Shlomo Y., Daniel S.E., et al. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathological study//Neurology, 1992.-V.42.-P.1142- 1146.
- Hughes AJ, Colosimo C, Kleedorfer B, et al. The dopaminergic response in multiple system atrophy.// J. Neurol. Neurosurg. Psychiatry, 1992.-V.55.-P.1009−1013.
- Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson’s disease. //Arch. Neurol., 1993.-V.50.-P.140−148.
- Hurtig H.I., Trojanowski J.Q., Galvin J. et al. Alfa-sinuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease .// Neurology, 2000. -V.54. -P. 1916−1921.
- Ito H.,.Kusaka H., Matsumoto S. et al. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy //Neurology, 1996. -V.47. -P. 1291 -1296.
- Jack CR, Mokri B, Laws ER, et al. MR findings in normal pressure hydrocephalus: significance and comparison with other forms of dementia.// J. Comput. Assist. Tomogr., 1987.-V.11.-P.923−931.
- Jacobs D.M., Marder K., Cote L.J. et al. Neuropsychological characteristics of preclinical dementia in Parkinson’s disease .//Neurology, 1995. -V.45. -P.1691−1696.
- Jahanshahi M, Rowe J, Saleem T, et al. Striatal contribution to cognition: working memory and executive function in Parkinson’s disease before and after unilateral posteroventral pallidotomy. Hi. Cogn. Neurosci., 2002.-V.14.-P.298−310.
- Jankovic J. Post-traumatic movement disorders: central and peripheral mechanisms //Neurology, 1994. -V.44. -P.2006−2014.
- Jancovic J. International Classification of Diseases, Tenth Revision: Neurological Adaptation (ICD-10NA):Extrapyramidal and Movement Disorders // Movement Disorders, 1995, -V.10. -№ 5. -P.535−540.
- Jancovic J. Progressive supranuclear palsy. //In:R.T.Jonson, J.W.Griffin (eds) Current therapy in neurologic disease. StLouis. Mosby, 1997. P.279−282.
- Jankovic J, Nutt JG, Sudarsky L. Classification, diagnosis and etiology of gait disorders. //In: Ruzicka E, Hallet M, Jankovic J, editors. Gait disorders. Advanced in neurology. Vol. 87. Philadelphia: Lippincott Williams & Wilkins, 2001.
- Jankovic J. Rajput AH, McDermott MP, et al. The evolution of diagnosis in early Parkinson’s disease. Parkinson Study Group.// Arch. Neurol., 2000.-V.57.-P.369−372.
- Jankovic J. Parkinson’s disease therapy: tailoring choices for early and late disease, young and old patients. Clin Neuropharmacol 2000−23:252−61.
- Janowsky D.S., Risch S.C., Gillin J.C. Adrenergic-cholinergic balance and the treatment of affective disorders//Prog.Neuropsychopharmacol.Biol.Psychiatry, 1983. -V.7-P.297−307.
- JeIlinger K. Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer’s disease// J. Neurol. Neurosurg. Psychiatry, 2000, -V.68. -P.246−256.
- Jellinger K. Structural basis of dementia in neurodegenerative disorders. //J. Neural. Transm. Suppl., 1996.-V.47.-P. 1−29.
- Jellinger K. The pathology of parkinsonism.// In: Movement disorders 2. Eds. C.D.Marsden, S.Fahn. Butterworth, 1987. P. 124−165.
- Jellinger K.A., Bancher C. Neuropathology. //In: Litvan I., Agid Y. (eds). Progressive supranuclear palsy: clinical and research approaches. New York, Oxford, 1993. -P. 44−48.
- Jendroska K., Rossor M. N., Mathias C. J. et al. Morphological overlap between corticobasal degeneration and Pick’s disease // Mov. Disord, 1995. Vol. 10. — P. 111−114.
- Jog M.S., Lang A. Chronic acquired hepatocerebral degenerationxase report and new insight //Mov.disord., 1995 -V.10. -N.6. -P.714−722.
- Johnson R. Event-related brain potentials //In:Litvan I., Agid Y., eds. Progressive supranuclear palsy. Oxford University Press, 1992. -P.44−88.
- Jones A.C., Yamamura Y., Almasy L. et al. Autosomal recessive juvenile parkinsonism maps to 6q25.2-q27 in four ethnic groups: detailed genetic mapping of the linked region.//Am. J. Hum. Genet., 1998. -V.63. -P.80−87.
- Jordan BD, Relkin NR, Ravdin LD, et al. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing.// JAMA, 1997.-V.278.-P.136−140.
- Jordan BD. Chronic traumatic brain injury associated with boxing.// Semin. Neurol., 2000.-V.20.-P.179−185.
- Jordan N., Sagar H.J., Cooper J.A. Cognitive components of reaction time in Parkinson’s disease//J. Neural. Neurosurg. Psychiatry, 1992.-V.55.-P.658−664.
- Kalra S, Bergeron C, Lang AE. Lewy body disease and dementia: a review.// Arch. Intern. Med., 1996.-V. 156.-P.487−493.
- Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia.// Neurology, 2000.-V.55.-P.1368−1375.
- Kertesz A. Frontotemporal dementia, Pick disease, and corticobasal degeneration. One entity or 3?//Arch. Neurol., 1997.-V.54.-P.1427−1429.
- Ketonen L.M., Berg M. Clinical, neuroradiology. London, Arnold, 1997. -178 P.
- Kimber J, Mathias CJ, Lees AJ, et al. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy.// Brain, 2000.-V.123.-P. 14 221 430.
- Kirby R, Fowler C, Gosling F, et al. Urethro-vesical dysfunction in progressive autonomic failure with multiple system atrophy.// J. Neurol. Neurosurg. Psychiatry., 1986.-V.49.-P.554−562.
- Kitada T., Asakawa S., Hattori N. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.//Nature, 1998. -V.392. -P. 605−608.
- Klatka L.A., Elam D.L., Schiffer R.B. Psychiatric features in diffuse Lewy body disease: clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups//Neurology, 1996. -V.47. -P.l 148−1152.
- Klawans H.L. Hemiparkinsonism as a late complication of hemiatrophy: a new syndrome.// Neurology, 1981.-V.31.-P. 625−628.
- Klawans HL, Gegen D, Bruyn GW. Prolonged drug-induced parkinsonism.// Confin. Neurol., 1973.-V.35.-P.368−377.
- Kohlhepp W., Kuhn W., Kruger H. Extrapyramidal features in central Lyme borreliosis. //Eur.Neurol, 1989. -V.29. -P. 150.
- Komori T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick’s disease. //Brain Pathol., 1999.-V.9.-P.663−679.
- Kompoliti K, Goetz CG, Boeve BF, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration.// Arch. Neurol., 1998.-V.55.-P.957−961.
- Kompoliti K, Goetz CG, Leurgans S, et al. Freezing in Parkinson’s disease: resistance to visual cue walking devices.// Mov. Disord., 2000.-V.15.-P.309−312.
- Kompoliti K, Goetz CG, Litvan I, et al. Pharmacological therapy in progressive supranuclear palsy. //Arch. Neurol., 1998.-V.55.-P.1099−1102.
- Konagaya M, Konagaya Y, Iida M. Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy. //J. Neurol. Neurosurg. Psychiatry, 1994.-V.57,-P. 1528−1531.
- Korten J.J., Meulstee J. Olfactory disturbances in parkinsonism//Clin. Neurol. Neurasurg., 1980.-V.82.-P.113−118.
- Kosaka K. Dementia and neuropathology in Lewy body disease IIAdv. Neurol., 1993. -V.60. -P.456−463.
- Kosaka K., Matsushita M., Oyanagi S. et al. A clinicopathological study of the «Lewy body disease» //Psych, et Neurol. Jap., 1980
- Kostic V, Przedborski S, Flaster E, et al. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson’s disease. //Neurology, 1991.-V.41.-P.202−205.
- Kostic VS, Marinkovic J, Svetel M, et al. The effect of stage of Parkinson’s disease at the onset of levodopa therapy on development of motor complications.// Eur. J. Neurol., 2002.-V.9.-P.9−14.
- Koto A, Rosenberg G, Zingesser LH, et al. Syndrome of normal pressure hydrocephalus: possible relation to hypertensive and arteriosclerotic vasculopathy.// J. Neurol. Neurosurg. Psychiatry, 1977.-V.40.-P. 73−79.
- Kraft E, Winkelmann J, Trenkwalder C, et al. Visual hallucinations, white matter lesions and disease severity in Parkinson’s disease. //Acta Neurol. Scand., 1999.-P. 362−367.
- Kraft E, Schwartz J, Trenkwalder C, et al. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?//Arch. Neurol., 1999.-V.56.-P.225−228.
- Kramer JH, Reed BR, Mungas D, et al. Executive dysfunction in subcortical ischaemic vascular disease.// J. Neurol. Neurosurg. Psychiatry, 2002.-V.72.-P.217−220.
- Krauss J.K., Grossman R.G., J. Jankovic. Improvement of parkinson’s signs after vascular lesions of the basal ganglia.// Mov. disord., 1995. V. ll. suppl l.-P. 183.
- Krauss J.K., Trankle R., Kopp K.-H. Post-traumatic movement disorders in survivors of severe head injury //Neurology, 1996. -V.47. -P.1488−1492.
- Krauss JK, Regel JP, Vach W, et al. Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus of the elderly: can it predict outcome after shunting?// Neurosurgery, 1997.-V.40.-P.67−74.
- Krauss JK, Regel JP, Vach W, et al. Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly.// Stroke, 1996.-V.27.-P. 1−6.
- Krieger D., Krieger S., Jansen O. et al. Manganese and chronic hepatic encephalopathy// Lancet, 1995.-V.346. -P.270−274.
- Kulisevsky J., Berthier M.L., Pujol L. Hemiballismus and secondary mania following a right thalamic infarction//Neurology, 1993. -V.43. -P. 1422−1424.
- Kumar R., Bergeron C., Pollanen M.S. et al. Cortico-basal ganglionic degeneration //In: J. Jankovic, E. Tolosa (eds). Parkinson’s disease and movement disorders. 3nd ed. Baltimore. Williams&Wilkins, 1998. -P.357−365.
- Kuypers H.G.J.M. Anatomy of the descending pathways//In: V.B.Brooks (ed). Handbook of physiology.Sec.l. The nervous system.Vol.2, Motor control, Part l. Bethesda, MDA American Physiological Society, 1981 -P.597−666.
- Labadie E.L., Awerbach G.I., Hamilton R.H., et al. Falling and postural deficits due to acute basal ganglia lesions.// Arch.Neurol., 1989. V.45. — P.492−496.
- Lakke J.P. Axial apraxia in Parkinson’s disease. // J. Neurol. Sei. -1985. -V.69. P.37−46
- Lallement F., Rolland Y., Prunier C. Et al. Is iron involved in pathphysiology of multiple system atrophy?// Mov.disord., 2000. -V.15(suppl.3)-P.207.
- Lalonde R., Botez-Marquard T. The neurological basis of movement initialion//Rev. Neurosci., 1997.-V.8.-P.35−54.
- Lang AE, Bergeron C, Pollanen MS, et al. Parietal Pick’s disease mimicking cortical-basal ganglionic degeneration. //Neurology, 1994.-V.44.-P. 1436−1440.
- Lang AE, Lozano A, Taskei R, et al. Neuropsychological and behavioral changes and weight gain after medial pallidotomy.//Ann. Neurol., 1997.-V.41.-P.834−836.
- Lange K.W., Robbins T. W, Marsden C.D. et al. L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.// Psychopharmacology, 1992. -V.107. -P. 394−404.
- Lantos PL, Papp MI. Cellular pathology of multiple system atrophy. //J. Neurol. Neurosurg. Psychiatry, 1994.-V.5 7.-P. 129−133.
- Laplane D., Levasseur M., Pillon B. et al. Obsessive-compulsive and other behavioral changes with bilateral basal ganglia lesions //Brain, 1989. -V.l 12. -P.699−725.
- Latash M. Neurophysiological basis of movement //Human Kinetics, 1998. -268 P.
- Lee CS, Schulzer M, Mak E, et al. Patterns of asymmetry do not changeover the course of idiopathic parkinsonism: implications for pathogenesis.//Neurology, 1995.-V.45.-P.435−439.
- Lee M.S., Marsden C.D. Movement disorders following lesions of the thalamus or subthalamic region. //Mov Disord., 1994. -N9. -P. 493−507.
- Lees AJ. The Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).//Marsden CD, Fahn S, Movement Disorders 2. London: Butterworths, 1987.-P.272−287.
- Leiguarda R, Merello M, Balej J, et al. Disruption of spatial organization and interjoint coordination in Parkinson’s disease, progressive supranuclear palsy, and multiple system atrophy.// Mov. Dis., 2000.-V.-15.-P.627−640.
- Leiguarda R. C., Pramstaller P. P., Merello M. et al. Apraxia in Parkinson’s disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism // Brain. 1997. -Vol. 120.-P. 75−90.
- Leiguarda R., Lees A. J., Merello M. et al. The nature of apraxia in corticobasal degeneration // J. Neurol. Ncurosurg. Psychiatr. 1994. — Vol. 57. — P. 455−459.
- Leiguaula R.C., Marsden C.D. Limb apraxias. Higher-order disorders of sensorimotor integration//Brain, 2000. V. l23. -P.860−879.
- Lendon C.L., Lynch T., Norton J. et al. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21−22. //Neurology, 1998. -V.50. -P. 1546−1555.
- Lennox G, Jackson M, Lowe J. Corticobasal degeneration manifesting as a frontal lobe dementia.// Ann. Neurol. 1994.-V.36.-P.273−274.
- Lennox G.G., Lowe J.S. Dementia with Lewy bodies //In: Bailliere’s Clinical Neurology, 1997. -V.6. -P 147−165.
- Levin B.E., Katzen H.L. Early cognitive changes and nondementing behavioral abnormalities in Parkinson’s disease.// In: W.J.Weiner, A.E.Lang. Behavioral Neurology of movement disorders. Advances in Neurology, 1995. -V.65. -P.85−95.
- Levin B.E., Llabre B.M., Weiner W.J. Cognitive impairments associated with early Parkinson’s disease//Neurology, 1989.-V.39.-P.557−561.
- Levin B.E., Llabre M.M., Reisman S. A retrospective analysis of the effects of anticholinergic medication on memory performance in Parkinson’s disease.//J. Neuropsychiatry Clin. Neurosci, 1991.-V.3.-P.412−416.
- Levin B.E., Llabre M.M., Reisman S., et al. Visuo-spatial impairment in Parkinson’s disease//Neurology, 1991 .-V.-41 .-P.365−369.
- Levin B.E., Tomer R., Rey G. Clinical correlates of cognitive impairments in Parkinson’s disease.// In Huber S.J., Cummings J.L., eds. Parkinson’s disease: neurobehavioral Aspects. New York: Oxford Press- 1992.
- Levy G, Tang MX, Cote LJ, et al. Do risk factors for Alzheimer’s disease predict dementia in Parkinson’s disease? An exploratory study. //Mov. Disord., 2002.-V.17.-P/250−257.
- Levy R., Ruberg M., Herrero M.T. et al. Alterations of GABAergic neurons in the basal ganglia of patients with parogressive supranuclear palsy.// Neurology, 1995. -V.45. -P. 127−134.
- Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson’s disease: the use of extrinsic, visual cues.// Brain, 2000.-V.I23.-P.2077−2090.47?.Lezak M. Neuropsychological assessment. 3rd ed. //New York: Oxford Univ. Pr., 1995.
- Liberini P, Parola S, Spano PF, et al. Olfaction in Parkinson’s disease: methods of assessment and clinical relevance.// J. Neurol., 2000.-V.247.-P.88−96.
- Liston R., Tallis R.C. Gait apraxia and multi-infarct states.// In Parkinson’disease and parkinsonism in the elderly. J. Meara, W.C.Koller. Cambridge, 2000. -P.98−110.
- Litvan I. Progressive supranuclear palsy and corticobasal degeneration // Clin.Neurol., 1997.- V.6. P.167−185.
- Litvan 1. Parkinsonism-Dementia syndromes// In: J. Jankovic, E. Tolosa (eds). Parkinson’s disease and movement disorders. 3nd ed. Baltimore. Williams&Wilkins, 1998. -P.245−262.
- Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.// Neurology, 1996.-V.47.-P. 1−9.
- Litvan I, Agid Y, Goetz C, et al. Validity of clinical diagnosis of corticobasal ganglionic degeneration. //Mov. Disord., 1996.-V.11.-P.354−355.
- Litvan I., Agid Y., Goetz C. et al. Accuracy of the clinical diagnosis of corticobasal degeneration //Neurology, 1997. -V.48. -P. 119−125.
- Litvan I, Baker M, Hutton M. Tau haplotype does not affect the onset, symptom severity, or survival in progressive supranuclear palsy.// Neurology, 2001.-V.57.-P.138−140.
- Litvan I, Blesa R, Clark K, et al. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy. //Ann. Neurol., 1994.-V.36.-P.55−61.
- Litvan I., Campbell G., Mangone C.A. et al. Wich clinical features differentiate progressive supranuclear palsy from related disoreders? //Brain, 1997. -V.120. -P.65−74.
- Litvan I, Cummings JL, Mega M. Neuropsychiatrie features of corticobasal degeneration. Hi. Neurol. Neurosurg. Psychiatry, 1998a.-V.65.-P.717−721.
- Litvan I, Gomez C, Atack JR, et al. Physostigmine treatment of progressive supranuclear palsy. //Ann. Neurol., 1989.-V.-26.-P.404−407.
- Litvan I, Grafman J, Gomez C, et al. Memory impairment in patients with progressive supranuclear palsy.// Arch. Neurol., 1989.-V.-46.-P.765−767.
- Litvan I, Grimes DA, Lang AE, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Hi. Neurol., 1999.-V.246 P. l-5.
- Litvan I, McKee A. Clinicopathologic case report. Dementia with Lewy bodies (DLB).// J. Neuropsychiatry Clin. Neurosci, 1999.-V.11.-P.107−112.
- LitvanI., Mega M.S., Cummings J.L. et al. Neuropsychiatrie aspects of progressive supranuclear palsy. //Neurology, 1996. -V. 48. -P.l 19−125.
- Litvan I, Mohr E, Williams J, et al. Differential memory and executive functions in demented patients with Parkinson’s and Alzheimer’s disease.// J. Neurol. Neurosurg. Psychiatry, 1991.-V.54,-P.25−29.
- Litvan I, Paulsen JS, Mega MS, et al. Neuropsychiatrie behavioral assessment of patients with hyperkinetic and hypokinetic movement disorders. //Arch. Neurol., 1998c.-V.55.-P.1313−1319.
- Litvan I, Phipps M, Pharr VL, et al. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. //Neurology, 2001.-V.57.-P.467−473.
- Litvan I., Bhatia K., Burn D.J. et al. SIC Task force appraisal of clinical diagnostic criteria for parkinsonian disorders.//Mov. Disord., 2003. — V. 18. P. 467−486.
- Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic imaging of 3301 elderly people. The cardiovascular health study.// Stroke, 1996.-V.27.-P. 1274−1282.
- Lopez O.L., Smith G., Meitzer C.C. et al. Dopamine systems in human immunodeficiency virus-associated dementia.//J.Neuropsychiatry, Neuropsychology and Behavioral Neuiology, 1999. -V.12. -P. 184−192.
- Lopez OL, Litvan I, Catt KE, et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. //Neurology, 1999.-V.53.-P. 1292−1299.
- Louis E.D., Klatka L.A., Liu Y. et al. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson’s disease //Neurology, 1997. -V.48. -P.376−380.
- Louis ED, Goldman JE, Powers JM, et al. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. //Mov. Disord., 1995.-V.10(Sup. 2).-P.188−194.
- Louis ED, Marder K, Cotii L, et al. Age at death is significantly younger in patients with Parkinson’s disease who have dementia. //Neurology, 1996.-V.46(Suppl).-A377.
- Lowenthal A. Striatopallidodentate calcifications.// In: Handbook of clinical neurology, vol.49 (eds. P. Vinken, G. Bruyn, H. Klawans). Amsterdam: Elsevier, 1986. -P. 417−436.
- Lu C.-S., Tsai C.-H., Chen R.-S. Arteriosclerotic parkinsonism.// Mov. disord., 1994. V. 9, suppl l.-P. 84.
- Lu CS, Huang CC, Chu NS, Calne DB. Levodopa failure in chronic manganism // Neurology, 1994. -V.44. -P. 1600−1602.
- Lucking C.B., Abbas N., Durr A., et al. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism.// Lancet, 1998. -V.352. -P. 1355−1356.
- Luginger E., Seppi K., Litvan I. Et al. Associated Alzheimer’s pathology modifies the natural history of demnentia with Lewy bodies: a clinicopathological stydy//Mov. Disord., 2000 -V.15 (Suppl.3) -P.226.
- Lynch T., Sano M., Marder K.S. et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.//Neurology 1994. -V.44.1. P. 1878−1884.
- Makoff AK, Graham JM, Arranz MJ, et al. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson’s disease. //Pharmacogenetics, 2000.-V.-10.-P.43−48.
- Manes F, Sahakian B, Clark L, et al. Decision-making processes following damage to the prefrontal cortex.// Brain, 2002.-V.125.-P.624−639.
- Manyam B.V., Walters A.S., Narla K.R. Bilateral striopallidodentate calcinosis // Mov.disord., 2000-V.15. (Supl.3). -P.233.
- Marder K, Tang MX, Cote L, et al. The frequency and associated risk factors for dementia in patients with Parkinson’s disease.// Arch. Neurol., 1995.-V.52(7).-P.695−701.
- Marder KS, Bell KL, Foster NL, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex.// Neurology, 1994.-V.44.-P. 18 781 884.
- Marek K, Seibyl J, Shoulson I, et al. Dopamine transporter brain imaging to assess the effects of pramipexole versus levodopa on Parkinson disease progression. //JAMA, 2002.-V.387.-P.1653−1661.
- Mark M.H., Sage J.I., Walters A.S. Binswangens disease presenting as levodopa-responsive parkinsonism // Mov. disord., 1995. V. 10. — P. 450−454.
- Marsden C.D. The mysterious motor function of the basal ganglia: the Robert Wartenberg lecture//Neurology, 1982. -V.32. -P.514−539.
- Marsden C.D. Motor dysfunction and movement disorders.// In: Diseases of Nervous System. Clinical neurobiology. Ed. A.K.Asbury, G.M.McKhann, W.I.McDonald.-2nd ed.- W.B.Saunders, 1992, — P.309−318.
- Marsden C.D. Parkinson’s disease//J. Neurol. Neurosurg. Psychiatry, 1994.-V.57.-P.672−681.
- Marsden C.D., Fahn S. Problems in Parkinson’s disease and other akinetic-rigid syndromes // In: C.D.Marsden, S. Fahn (eds). Movement disorders 3. Cambrridge, Butterworth Heinemann, 1994. -P.I 17−123
- Marsden C.D., Thompson P. Toward a nosology of gait disorders: descriptive classification.//In J.C.Masdeu, L. Sudarsky, L. Wolfson (eds). Gait disorders of aging: falls and therapeutic strategies. Lippincott-Raven, New York, 1997. -P.135−146.
- Marsden C.D., Obeso J. A. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson’s disease.//Brain, 1994. -V.117. -P.877−897.
- Marshall VG, Bradley WG Jr, Marshall CE, et al. Deep white matter infarction: correlation of MR imaging and histopathologic findings.// Radiology, 1988.-V.167.-P. 517−522.
- Marti-Masso JF, Poza JJ. Cinnarizine-induced parkinsonism: ten years later.// Mov. Disord., 1998.-V.13.-P.453−456.
- Martin J.P. The basal ganglia and posture.// London: Pitman, 1967.
- Martin WR, Roberts TE, Ye FQ, et al. Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance// Can. J. Neurol. Sei, 1998.-V.25.-P.44−47.
- Martland H.S.Punch drunk//JAMA, 1928.-V.91.-P.1103−1107.
- Masdeu J.C., Alampur U., Cavaliere R. et al. Astasia and gait failure with damage of the pontomesencephalic region.//Ann.Neurol., 1994. -V.35. -P.619−625.
- Massman P.J., Kreiter K.T., Jankovic J., et al. Neuropsychological functioning in cortico-basal ganglionic degeneration //Neurology, 1996. -V.46. -P.720−726.
- Mathew NT, Meyer JS, Hartmann A, et al. Abnormal cerebral spinal fluid-blood flow dynamics.// Arch. Neurol., 1975.-V.32.-P. 657−664.
- Mathias C.J., Kimber J.R. Treatment of postural hypotension// J Neurol. Neurosurg. Psychiatry, 1998.-V.65.-P. 285−289.
- Mathuranath P. S., Xuereb J.H., Bak T., et al. Corticobasal ganglionic degeneration and/or frontotemporal dementia?//J.Neurol. Neurosurg. Psychiatry, 2000. -V.68. -P.304−312.
- Matilla PM, Roytta M, Torikka H, et al. Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease.// Acta Neuropathol., 1998.-V.95.-P.576−582.
- Matsumine H., Saito M., Shimoda-Matsubayashi S. et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2−27. //Am. J. Hum. Genet., 1997. -V.60. -P.588−596.
- Matsuo H., Takashima H., Kishikawa et al. Pure akinesia: an atypical manifestation of progressive supranuclear palsy //J.Neurol.Neurosurg.Psychiatry, 1991. -V.54.-P.397−400.
- Mayo J., Arias M., Leno C. et al. Vascular parkinsonism and periartritis nodosa.//Neurology, 1986. -V.36. -P.874
- McKeith I.G., Galasko D., Kosaka K. et al. Consensus guidlines for the clinical and pathologic diagnosis of dementia with Lewy bodies //Neurology, 1996. -V.47. -P. 113−1124.
- Meco G., Gasparini M., Doricchi F. Attentional fuctions in multiple system atrophy and Parkinson’s disease // J. Neurol. Neurosurg. Psychiatry, 1996. -V.60. -P. 393−398.
- Mega M.S., Masterman D.L., Benson F. et al. Dementia with Lewy bodies //Neurology, 1996. -V.47. -P.1403−1409.
- Mega MS, Cummings JL. Frontal-subcortical circuits and neuropsychiatrie disorders.// J. Neuropsych. Clin. Neurosci, 1994.-V.16.-P.358−370.
- Mega MS. Masterman DL, Benson DF, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathological criteria. //Neurology, 1996.-V.47.-P.1403−1409.
- Melamed E. Neurobehavioral abnormalities in Parkinson’s disease // In: R.L.Watts, W.C.Koller (eds). Movement disorders. New York McGraw-Hill, 1997. -P.257−262.
- Melamed E, Achiron A, Shapira A, et al. Persistent and progressive parkinsonism after discontinuation of chronic neuroleptic therapy: an additional tardive syndrome?// Clin. Neuropharmacol., 1991 .-V. 14.-P.273−278.
- Mendez M.F., Adams N.L., Lewandowski K.S. Neurobehavioral changes associated with caudate lesions //Neurology, 1989. -V.39. -P.349−354.
- Mendez MF. Corticobasal ganglionic degeneration with Balint’s syndrome. //J. Neuropsych. Clin. Neurosci, 2000.-V. 12.-P.273−275.
- Mendez MF. The neuropsychiatrie aspects of boxing.// Int. J. Psychiatry Med., 1995.-V.25.-P.249−262.
- Menza M. The personality associated with Parkinson’s disease. //Curr. Psychiatry Rep., 2000.-V.2.-P.421−426.
- Mesholam RI, Moberg PJ, Mahr RN, et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases.// Arch. Neurol., 1998.-V.55.-P.84−90.
- Messa C, Volonte MA, Fazio F, et al. Differential distribution of striatal 123I. beta-CIT in Parkinson’s disease and progressive supranuclear palsy, evaluated with single-photon emission tomography. //Eur. J. Nucl. Med., 1998.-V.25.-P.1270−1276.
- Mesulam M. Frontal cortex and behavior. //Ann. Neurol., 1986.-V.19.-P.320−325.
- Meyer J.S., Barron D. Apraxia of gait: a clinico-pathlogical study.// Brain, 1960. -V.83. -P.61−84.
- Micheli F, Pardal MF, Gatto M, et al. Flunarizine and cinnarizine-induced extrapyramidal reactions.// Neurology, 1987.-V.37:.-P.881−884.
- Miwa H, Kondo T, Mizuno Y. Striatonigral degeneration and sporadic olivopontocerebellar atrophy: a consideration of the clinical entity of multiple system atrophy. //No To Shinkei, 1999.-V.51.-P.305−312.
- Miyazaki H, Saito Y, Kijima Y, et al. An autopsy case of corticobasal degeneration mimicking frontal Pick’s disease. //No to Shinkei, 1997.-V.49.-P.277−282.
- Mizuno Y, Hattorf N, Mori H, et al. Parkin and Parkinson’s disease.// Curr. Opin. Neurol., 2001.-V.14.-P.477−482.
- Mohr E., Fabbrini G., Ruggieri S., et al. Cognitive concomitants of dopamine system stimulation in parkinsonian patients//J. Neur. Neurosurg. Psychiatry, 1987. -V.50.-P.1192−1196.
- Mohr E., Mendis T., Grimes J.D. Late cognitive changes in Parkinson’s disease with an emphasis on dementia.// In: W.J.Weiner, A.E.Lang. Behavioral Neurology of movement disorders. Advances in Neurology, 1995. -V.65. -P.85−95.
- Molinuevo JL, Munoz E, Valldeoriola F, et al. The eye of the tiger sign in cortical-basal ganglionic degeneration.//Mov. Disord., 1999.-V.14.-P. 169−171.
- Montastruc J.L., Llau M.E., Rascol O. et al. Drug-induced parkinsonism: a review //Fundamental and clinical pharmacology, 1994. -V.8. -P.293−306.
- Montgomery P., Silverstein P., Wichmann R., et al. Spatial updating in Parkinson’s disease.//Brain Cogn, 1993.-V.23.-P.113−126.
- Morris H.R., Lees A.J., Wood N.W. Neurofibrillary tangle parkinsonian disorders tau pathology and tau genetics//Movement disorders, 1999. -V.14. -P.731−736.
- Morris ME, Iansek R, Matyas TA, et al. Stride length regulation in Parkinson’s disease: normalization strategies and underlying mechanisms.// Brain, 1996.-V.119.-P.551−568.
- Morris ME, Iansek R, Matyas TA, et al. The pathogenesis of gait hypokinesia in Parkinson’s disease. //Brain, 1994.-V. 117.-P. 1169−1181.
- Morris R.G., Downes J.J., Sahakian B.J., et al. Planning and spatial working memory in Parkinson’s disease//.!. Neurol. Neurosurg. Psychiatry, 1988.-V.51.-P.757— 766.
- Morris S., Olichney J., Corey-Bloom J. Psychosis in dementia with Lewy bodies //Semin.Clin.Neuropsychiatry, 1998. -V.3. -P.51−60.
- Morrish P.K., Rakshi J.S., Sawle G.V. et al. Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with 18 °F.dopa PET//J. Neurol. Neurosurg. Psychiatry, 1998.-V.64.-P.314−319.
- Morrish P.K., Sawle G.V., Brooks D.J. An i8 °F.dopa PET and clinical study of the rate of progression in Parkinson’s disease//Brain, 1996.-V.119.-P.585−591.
- Mouradian MM. Recent advances in the genetics and pathogenesis of Parkinson disease.// Neurology, 2002.-V.58.-P. 179−185.
- Muller J, Wenning GK, Jellinger K, et al. Progression of Hoehn and Yahr stages in parkinsonian disorders: a clinicopathologic study. //Neurology, 2000.-V.55.-P.888−891.
- Muller J, Wenning GK, Verny M, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.// Arch. Neurol., 2001 .-V.58.-P.259−264.
- Muller J, Wenning GK, Wissel J, et al. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.// J. Neurol., 2002.-V.249.-P.300−304.
- Munoz DG, Hastak SM, Harper B, et al. Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging. //Arch. Neurol., 1993.-V.50.-P.492−497.
- Munro-Davies L.E., Winter J., Aziz T.Z., et al. The role of the pedunculopontine region in basal-ganglia mechanisms of akinesia.//Exp. Brain Res., 1999. -V.129. -P.511−517.
- Murrow R.W., Schweiger G.D., Kepes J.J., et al Parkinsonism due to a basal ganglia lacunar state: clinicopathological correlation. // Neurology, 1990. V. 40. — P. 897−900.
- Nagahama Y, Fukuyama H, Tuijanski N, et al. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.// Mov. Disord., 1997.-V.12.-P.691−696.
- Nahmias C., Garnett E.S., Firnau G., et al. Striatal dopamine distribution in Parkinsonian patients during life//J. Neurol. Sei., 1985.-V.69.-P.223−230.
- Naito Y., Kuzuhara S. Postural instability in patients with vascular parkinsonism and effect of L-DOPS.//Mov.disord" 1997. -V.12 (suppl.l). -P.88.
- Narabayashi H. Akinesia in parkinsonism//ln: A.B.Joseph, R.R.Young (eds). Movement Disorders in Neurology and Neuropsychiatry. -2nd ed. Oxford, Blackwell Science, 1999.-P.185−188.
- Neary D., Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.//Neurology, 1998. V.51. -P.1546−1554.
- Negrotti A, Calzetti S. A Long-term follow-up study of cinnarizine- and flunarizine-induced parkinsonism.// Mov. Disord., 1997.-V.12.-P. 107−110.
- Newman G.C. Treatment of progressive supranuclear palsy with tricyclic antidepressants //Neurology, 1985. -V.35. P. 1189.
- Nieforth K.A., Golbe L.I. Retrospective study of drug response in 87 patients with progressive supranuclear palsy. // Clin. Neuropharmacol, 1993. -V.16. -P.338.
- Nisipeanu P., Paleacu D., Korczyn A.D. Infectious and postinfectious parkinsonism // In: R.L.Watts, W.C.Koller (eds). Movement disorders. New York McGraw-Hill, 1997. P.307−313.
- Nutt J.G. Gait and balance disorders: a syndrome approach.// In: R.L.Watts, W.C.Koller (eds). Movement disorders. New York McGraw-Hill, 1997, — P.687−699.
- Nutt JG, Carter JH, Van Houten L, et al. Short- and long-duration responses to levodopa during the first year of levodopa therapy. //Ann. Neurol., 1997.-V.42.-P.349−355.
- Nutt JG, Holford NHG. The response to levodopa in Parkinson’s disease: imposing pharmacological law and order. //Ann. Neurol. 996.-V.39.-P.561−573.
- Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly.// Neurology, 1993.-V.43.-P.268 279.
- Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson’s disease.// Brain, 2000,-V.123.-P.1767−1783.
- Papp M.I., Khan J.E., Lantos P.L. Glial cytoplasmotic inclusions in the CNS of patients with multiple system atrophy // J.Neurol. Sci, 1989. -V.94. -P.79−100.
- Papp ML, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.// Brain, 1994.-V.117.-P.235−243.
- Parati EA, Fetoni V, Geminiani GC, et al. Response to L-DOPA in multiple system atrophy. //Clin. Neuropharmacol., 1993 .-V. 16.-P. 139−144.
- Parkinson J. An essay on the shaking palsy. //Medical Classics, 1817.-V. 10(2).-P.964−997.
- Parsa MA, Bastani B. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson’s disease. //J. Neuropsychiatry Clin. Neurosci, 1998.-V.10.-P.216−219.
- Pasquier F, Delacourte A. Non-Alzheimer degenerative dementias. //Curr. Opin. Neurol., 1998.-V.11.-P.417−427.
- Pasquier F, Grymonprez L, Lebert F, et al. Memory impairment differs in frontotemporal dementia and Alzheimer’s disease. //Neurocase, 2001 .-V.7.-P. 161−171.
- Pastakia B, Polinsky R, Di Chiro G, et al. Multiple system atrophy (Shy-Drager syndrome): MR imaging.// Radiology, 1986.-V.159.-P.499−502.
- Paulson GW, Aotsuka A. Parkinsonian syndromes.// Semin. Neurol., 1993.-V.13.-P.359−364.
- Pearce JM. The Lewy body. //J. Neurol. Neurosurg. Psychiatry, 2001.-V.71.-P.214.
- Peigneux P, Salmon E, Garraux G, et al. Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. //Neurology, 2001.-V.57.-P.1259−1268.
- Pelletier J., Habib M.H., Khalil R. Putaminal necrosis after methanol intoxication //J.Neurol., Neurosurg., Psychiatry, 1992. -V.55. -P.234−235.
- Penney J.B. Multiple systems atrophy and nonfamilial olivopontocerebellar atrophy are the same disease // Ann.Neurol., 1995. -V.37. P.553−554.
- Perez-Tur J, Buee L, Morris HR, et al. Neurodegenerative diseases of Guam: analysis of TAU. //Neurology, 1999.-V.53.-P.411−413.
- Perina M., Gomez-Arevalo G., Garcia S. et al. Donepezil improves motor and cognitive function in patients with progressive supranuclear palsy// Mov.disord., 2000-V.15. (Supl.3). -P.225.
- Perl D.P., Olanovv C.W., Calne D. Alzheimer’s disease and Parkinson’s disease: distinct entities or extremes of a spectrum of neurodcgcneration?//Ann. Neurol., 1998.-V.44(Suppl 1).-S 19-S31.
- Perlmutter J.S., Tempel L.W., Black K.J. et al. MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia//Neurology, 1997. -V.49. -P.1432−1438.
- Perry E.K., Fairbrain A.F., Perry R. et al. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia// J.Neurochim., 1990. -V.55. -P. 1454−1456.
- Perry E.K., Marshall E., Perry R.H. et al. Cholinergic and dopaminergic activities in senile dementia of the Lewy body type//Alzheimer Dis. Assoc. Disord., 1990, V.4. -P.87−95.
- Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease. //Neuroreport, 1994.-V.5.-P.747−749.
- Perry J. Gait analysis: normal and pathological function.// Thorofare, New Jersey: Slack, Inc., 1992.
- Perry RH, Irving D, Blessed G, Fairbairn A, et al. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly.// J. Neurol. Sei. 1990.-V.95.-P.119−139.
- Pfaffenbach DD, Layton DD, Kearns TP. Ocular manifestations in progressive supranuclear palsy// Am. J. Ophthalmol., 1972.-V.74.-P.1179−1184.
- Pfann KD, Buchman AS, Cornelia CL, et al. Control of movement distance in Parkinson’s disease. //Mov. Disord., 2001.-V.16.-P.1048−1065.
- Pharr V, Litvan I, Brad DG, et al. Ideomotor apraxia in progressive supranuclear palsy: a case study.//Mov. Disord., 1999.-V.14.-P. 162−166.
- Pharr V, Uttl B, Stark M, et al. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. //Neurology, 2001.-V.56.-P.957−963.
- Piccini P, Pavese N, Canapicchi R, et al. White matter hyperintensities in Parkinson’s disease.// Arch. Neurol., 1995.-V.S2.-P. 191−194.
- Piccirilli M., D’Alessandro P., Finali G., et al. Neuropsychological follow up parkinsonian patients with and without cognitive impairment/ZDementia, 1994,-Vol 5(1).-P. 17−22.
- Picker W., Brugger S., Prayer D. et al. Severe akinetic syndrome resulting from bilateral basal ganglia lesions following bone marrow transplantation //Mov. Disord., 1999. -V.14. -P.525−528.
- Piggott M.A., Perry E.K., Marshall E.F. et al. Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity.//Biol. Psychiatry, 1998. -V.44. -P.765−774.
- Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders// Neurology, 1996.-V.46.-P.329−333.
- Pillon B, Dubois B, Lhermitte F, et al. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson’s disease, and Alzheimer’s disease.// Neurology, 1986.-V.36.-P.1179−1185.
- Pillon B, Dubois B, Ploska A, et al. Severity and specificity of cognitive impairment in Alzheimer’s, Huntington’s, and Parkinson’s diseases and progressive supranuclear palsy. //Neurology, 1991.- V.41.-P.634−643.
- Pillon B, Dubois B. Cognitive and behavioral impairments. In: Litvan I, Agid Y, editors. Progressive supranuclear palsy.// Oxford: Oxford Univ. Pr, 1992.-P.223−239.
- Pillon B., Deweer B., Michon A. et al. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? // Neurology, 1994. -V. 44. -P. 1264 -1270.
- Pillon B., Dubois B., Cusimano G., et al. Does cognitive impairment in Parkinson’s disease result from non-dopaminergic lesion//J. Neurol. Neurosurg. Psychiatry, 1989.-V.52.-P.201−206.
- Pillon B., Dubois B., Polska A. et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson’s disease and progressive supranuclear palsy // J. Neurol. Neurosurg. Psychiatry, 1995. -V.58. -P. 174−179.
- Pirker W, Asenbaum S, Bencsits G, et al. I231. beta-C1T SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.// Mov. Disord., 2000.-V.15.-P.1158−1167.
- Playford ED, Jenkins IH, Passingham RE, et al. Impaired mesial frontal and putamen activation in Parkinson disease: a positron emission tomography study .//Ann. Neurol., 1992.-V.32.-P.151−161.
- Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. //Neurology, 1997.-V.48.-P. 1094−1097.
- Poewe W, Seppi K. Treatment options for depression and psychosis in Parkinson’s disease. //J. Neurol., 2001.-V.248(Suppl 3).-III12−21.
- Poewe W.H., Wenning G.K. The natural history of Parkinson’s disease//Ann. Neurol., 1998.-V.44(Suppl 1).-S1-S9.
- Polinsky RJ. Multiple system atrophy. Clinical aspects, pathophysiology, and treatment. //Neurol. Clin., 1984.-V.2.-P.487−498.
- Polinsky RJ. Shy-Drager syndrome. //In: Jankovic J, Tolosa E, editors. Parkinson’s disease and movement disorders. Baltimore: Williams and Wilkins, 1993.-P, 191−204.
- Pollanen MS, Ksiezak-Reding H. The emerging molecular pathology of corticobasal ganglionic degeneration.// Mov. Disord., 1996.-V.—11.-P.350.
- Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. //Science, 1997.-V.276.-P.2045−2047.
- Poser S., Mollenhauer B., Kraubeta A., et al. How to improve the clinical diagnosis of Creitzfeldt-Jakob disease.//Brain, 1999. -V.122. -P.2345 2351.
- Pujol A., Pujol J., Graus F. et al. Hyperintense globus pallidus on Tl-weighted MRI in cirrhotic patients is associated with severity of liver failure//Neurology, 1993. -V.43. -P.65−69.
- Quinn N. Parkinsonism-recognition and differential diagnosis. //BMJ, 1995.-V.310.-P.447−452.
- Quinn N. Multiple system atrophy // In: C.D.Marsden, S. Fahn (eds). Movement disorders 3. Cambrridge, Butterworth Heinemann, 1994. -P.262−282.
- Quinn N., Critchley P., Marsden C.D. Young onset Parkinson’s disease. //Mov. Disord., 1987. -V.2.-P. 73−91.
- Quinn NP, Luthert P, Honavar M, et al. Pure akinesia due to Lewy body Parkinson’s disease: a case with pathology.// Mov. Disord., 1989.-V.4(l).-P.85−88.
- Quinn N., Marsden C.D. The motor disorders of multiple system atrophy //J. Neurol. Neurosurg. Psychiatry, 1993. -V.56. -P. 1239−1242.
- Quinn N., Wenning G., Marsden C.D. The Shy-Drager syndrome: what Shy and Drager really describe?//Arch. Neurol., 1995. -V.53. -P.656−657.
- Racette BA, McGee-Minnich L, Moerlein SM, et al. Welding-related parkinsonism: clinical features, treatment, and pathophysiology.// Neurology, 2001.-V.56.-P.8−13.
- Rafal RD, Grimm RJ. Progressive supranuclear palsy: functional analysis of the response to methysergide and antiparkinsonian agents.// Neurology, 1981.-V.31(12).-P.1507−1518.
- Rajput AH, Rodzilsky B, Hornykiewicz O, et al. Reversible drug-induced parkinsonism: clinicopathologic study of two cases.// Arch. Neurol., 1982.-V.39.-P.644−666.
- Rajput AH, Rozdilsky B, Ang L, et al. Significance of parkinsonian manifestations in essential tremor.// Can. J. Neurol. Sci, 1993.-V.20.-P.114−117.
- Ray W. L., Randall B. P. Cortico-basal degeneration: classical clinical features and natural history //Mov. Disord. — 1996. —Vol. 11,-P. 346.
- RebeitT. J. J- Kolodny E. H., Richardson E. P. Corticodentatonigral degeneration with neuronal achromasia // Arch. Neurol. — 1968. Vol. 18. — P. 20−33.
- Reed LA, Schmidt ML, Wszolek ZK, et al. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia («pallido-ponto-nigral degeneration»). //J. Neuropathol. Exp. Neurol., 1998.-V.57.-P.588−601.
- Reider-Groswasser I., Bornstein N.M., Korczyn A.D. Parkinsonism in patients with lucanar infarcts of the basal ganglia.//Eur.Neurol., 1995. V. 35. — P.46−49.
- Relman D.A. Whipple’s disease //In: W.M.Scheld, R.J.Whitley, D.T.Durack (eds). Infections of the central nervous system, 2-nd ed. Philadelphia. Lippincott-Raven, 1997. -P.579−590.
- Rey GJ, Tomer R, Levin BE, et al. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration.// Mov. Disord., 1995.-V.10.-P.106−110.
- Richard IH, Kurlan R. A survey of antidepressant drug use in Parkinson’s disease. //Neurology, 1997.-V.49.-P.1168−1170.
- Richards M., Bell K., Dooneief G. et al. Patterns of neuropsychological performance in Alzheimer’s disease patients with and without extrapyramidal signs //Neurology, 1993. -V.43. -P. 17 081 711.
- Riley D. E., Lung A. E., Lewis A. et al. Cortico-basal ganglionic degeneration // Neurology. — 1990. — Vol. 40. — P. 1203— 1212.
- Riley D.E. Secondary Parkinsonism //In: J. Jankovic, E. Tolosa (eds). Parkinson’s disease and movement disorders. 3nd ed. Baltimore. Williams&Wilkins, 1998. -P.317−339.
- Riley DE, Fogt N, Leigh RJ. The syndrome of «pure akinesia» and its relationship to progressive supranuclear palsy.// Neurology, 1994.-V.44.-P. 1025−1029.
- Rinne J. O., Lee M. S., Thompson P. D., et al. Corticobasal degeneration // Brain. — 1994. — Vol. 117, —P. 1183−1 196.
- Rinne J.O., Rummukainen J., Paljarvi L. et al. Dementia in Parkinson’s disease is related to neuronal loss in the medial substantia nigra //Ann. Neurol, 1989. -V.26. -P.47−50.
- Rinne JO, Laihinen A, Ruottinen H, et al. Increased density of dopamine D2 receptors in the putamcn. but not in the caudate nucleus in early Parkinson disease: a PET study with 1 lC.raclopride.// J. Ncuiol. Sei, 1995.-V.132.-P. 156−161.
- Robbins T.W., James M., Lange K.W. et al. Cognitive performance in multiple system atrophy // Brain, 1992. -V.115. -P.271−292.
- Robbins T.W., James M., Owen A.M. et al. Cognitive deficits in progressive supranuclear palsy, Parkinson’s disease and multiple system atrophy in tets sensitive to frontal lobe dysfunction// J. Neurol. Neurosurg. Psychiatry, 1994. -V.57. -P. 79−88.
- Rojo A., Pernaute R.S., Fontan A. et al. Clinical genetics of familial progressive supranuclear palsy. //Brain, 1999. -V.122. -P. 1233−1245.
- Roman G. White matter lesions and normal pressure hydrocephalus: Binswangens disease or Hakim syndrome.// AJNR, 1991.-V.12.-P. 40−41.
- Roos RAC, Jongen JCF, van der Velde EA. Clinical course of patients with Parkinson’s disease.// Mov. Disord., 1996.-V.11.-P.236−242.
- Rosenberg N.L., Myers J.A., Wayne W.R. Cyanide-induced parkinsonism: clinical, MRI and 6-fluorodopa PET studies //Neurology, 1989. -V.39. -P.142−144.
- Rosenberg R.N. Machado-Joseph disease: an autosomal dominant system degeneration.// Mov. Disord., 1992. -V.3. -P. 193−203.
- Saito H., Ejima A. Liver dysfunction and probable manganese accumulation in the brainsteam and basal ganglia //J.Neurol.Neurosurg.Psychiatry, 1995. -V.58. -P.760−761.
- Sakakibara R., Hattori T., Uchiyama T. et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation?// J. Neurol. Neurosurg. Psychiatry, 2000. -V.68. -P. 65−69.
- Sanlamaria J., Tolosa E., Valles A. Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism//Neurology, 1986.-V.36.-P.1130−1133.
- Savage C.R.Neuropsychology of subcortical dementias// In: Miguel E.C., Rauch S.L., Leckman J.F.(eds) Neuropsychiatry of the basal ganglia. The Psychiatric clinics of North America, 1997.-V.20. -P.911−932.
- S.Scaravilli T., Pramstaller P.P., Salerno A. et al. Involvement of the Onuf nucleus in progressive supranuclear palsy. //Mov.disord., 2000.-V.15. (Supl.3). -P.225
- Schwab J.F., England A.C. Projection technique for evaluating surgery in Parkinson’s disease.//In: Billingham F.H., Donaldson M.C. (eds.) Third symposium on Parkinson’s disease. Edinburgh: Livingstone, 1969. -P. 152−157.
- Schrag A., Ben-Solomo Y., Quinn N.P. Prevalence of progressive supranuclear palsy and multiplesystem atrophy: a cross-sectional study//Lancet, 1999. -V.354. -P.1771−1775.
- Schrag A., Kingsley D., Phatouros C. et al. Clinical usefulness of magnetic resonance imaging inmultiple system atrophy // J. Neurol. Neurosurg. Psychiatry, 1998. -V.65. -P. 65−71
- Schulz J.B., Klockgether T., Petersen D. et al. Multiple system atrophy: natural history, MRImorphology, dopamine receptor imaging with 123IBZM-SPECT // J. Neurol. Neurosurg. Psychiatry, 1995.-V.59. -P. 144−151.
- Scott B.L., Jancovic J. Delayed-onset progressive movement disorders after static brain lesion //Neurology, 1996. -V.46. -P.68−74.
- Sethi K., Adams R., Loring D. et al. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.//Ann. Neurol., 1988. -V.24. -P.692−699.
- Shandling M, Carlen PL, Lang AE. Parkinsonism in alcohol withdrawal: a follow-up study. //Mov. Disord., 1992.-V.5.-P.36−39.
- Shergill S., Mullan E., D’Ath P., et al. What is the clinical prevalence of Lewy body dementia //Int.J.Geriatr. Psychiatry, 1994. -V.9. -P.907−912.
- Shimomura T, Mori E, Yamashita H, et al. Cognitive loss in dementia with Lewy bodies and Alzheimer disease. //Arch. Neurol., 1998.-V.55.-P.1547−1552.
- Shinotoh H., Inoue 0., Hirayama K., et al. Dopamine Dl receptors in Parkinson’s disease and striatonigral degeneration: a positron emission tomography study//J. Neurol.Neurosurg. Psychiatry, 1993.-V.56.-P.467−472.
- Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension: a clinical-pathological study.// Arch. Neurol., 1960.-V.2.-P.511−527.
- Stacy M., Jankovic J. Differential diagnosis of Parkinson’s disease and parkinsonism-plus syndromes// Neurol.Clin., 1992.-V.10. -P.341−359.
- Starksiein S.E., Preziosi T.J., Bolduc P.L., et al. Depression in Parkinson’s disease.//J. Nerv. Mental. Dis., 1990.-V. 178.-P.27−31.
- Starkstein S.E. Neuropsychological and psychiatric differences between Alzheimer’s disease and Parkinson’s disease with dementia.// J.Neurol., Neurosurg., Psychiatry, 1996. -V.61 -P.381−387.
- Starkstein S.E., Berthier M.L., Bolduc P.L. et al. Depression in patients with early versus late onset of Parkinson’s disease.// Neurology, 1989. -V.39. -P. 1441−1445.
- Starkstein S.E., Bolduc P.L., Mayberg H.S., et al. Cognitive impairments and depression in Parkinson’s disease//J. Neurol. Neurosurg Psychiatry, 1991.-V.54.-P.941.
- Starkstein S.E., Merello M. Psychiatric and cognitive disorders in Parkinson’s disease. Cambridge Universitu Press, 2002. -229 P.
- Stolze H, Kuhtz-Buschbeck JP, Drucke H, et al. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson’s disease.// J, Neurol. Neurosurg. Psychiatry, 2001.-V.70.-P.289−297.
- Sudarsky L, Ronthal M. Gait disorders among elderly patients: a survey study of 50 patients. //Arch. Neurol., 1983.-V.40.-P.740−743.
- Takatsu H, Nagashima K, Murase M, et al. Differentiating Parkinson’s disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. //JAMA, 2000.-V.284.-P.44−45.
- Takeda M, Tachibana H, Okuda B, et al. Electrophysiological comparison between corticobasal degeneration and progressive supranuclear palsy. //Clin. Neurol. Neurosurg., 1998.-V.100.-P.94−98.
- Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson’s disease. //Mov. Disord., 1998.-V.13.-P.895−899.
- Tanigava A., Komiyama A., Hasegawa O. Truncal muscle tonus in progressive supranuclear palsy. // J.Neurol. Neurosurg. Psychiatry, 1998. -V.64. -V. 190−196.
- Tedeschi G., Litvan 1., Bonavita S. et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson’s disease and corticobasal degeneration .//Brain, 1997. -V.120. -P.1541−1552.
- Thajeb P. Gait disorders of multi-infarct dementia. CT and clinical correlation.// Acta Neurol. Scand., 1993. -V.87. -P.239−242.
- Thaut M.H., Mcintosh G.C., Rice R.R., et al. Rhythmic auditory stimulation in gait training for Parkinson’s disease patients.//Mov. Disord., 1996. -V.l 1. -P. 193−200.
- Thompson P.D., Marsden C.D. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger’s disease.// Mov.Disord., 1987. -V.2. P.1−8.
- Thompson PD, Day BL, Rothwell JC, et al. The myoclonus in corticobasal degeneration: evidence for two forms of cortical reflex myoclonus.// Brain, 1994.-V. 117.-P.1197−1208.
- Thompson PD, Day BL, Rothwell JC, et al. Clinical and electrophysiological findings in corticobasal degeneration.// Mov/ Disord., 1990.-V.5(Suppl 1).-P.43.
- Tinetti M.E., Backer D.I., McAvay G. et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community.//N.Engl.J.Med., 1994. -V.331. -P.821−825.
- Tison F, Wenning GK, Volonte MA, et al. Pain in multiple system atrophy.// J. Neurol., 1996.-V.243.-P.153−156.
- Tison F., Duche B., Loiseau P. Syndrome hemiparkinsonien vasculaire.// Rev. Neurol.Paris., 1993.-V. 149.-P. 565−567.
- Togasaki D.M., Tanner C.M. Epidemiologie aspects.// In: I. Litvan, C.G.Goetz, A.E.Lang (eds.) Corticobasal degeneration and related disorders. Adv.Neurol., V.82. -Philadelphia, 2000.-P.53−60.
- Tolosa E, Duvoisin R, Cruz-Sanchez FF, editors. Progressive supranuclear palsy: diagnosis, pathology and therapy. // Neural. Transm. Suppl., 1994.-V.42.-P. 15−31.
- Tolosa E., Valldeoriola F. Progressive supranuclear palsy. // In: Jankovic J., Tolosa E., eds. Parkinson’s disease and movement disorders. 3-d ed. Williams &Wilkins, 1998. -P.221 -244.
- Tolosa E.S., Santamaria J. Parkinsonism and basal ganglia infarcts.// Neurology, 1984. -V.34. P. 1516−1518.
- Torstenson R, Hartvig P, Langstrom B, et al. Differential effects of levodopa on dopaminergic function in early and advanced Parkinson’s disease. //Ann. Neurol., 1997.-V.41 .-P.334−340.
- Trenkwalder C., Schwarz J., Gebhard J. et al. Stanberg trial on epidemiology of parkinsonism and hypertension in the elderly. // Arch.Neurol., 1995. V.52. — P.1017−1022.
- Turjanski N., Lees A.J., Brooks D.J. Dopaminergic function in patients with posttraumatic parkinsonism: 18F-dopa PET study //Neurology, 1997. -V.49. -P. 183−189.
- Valente E.M., Bentivoglio A.R., Dixon P.H. et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK 6, on human chromosome lp35−36 //Am.J.Hum.Genet., 2001. -V.68. -P.895−900.
- Van Swieten JC, van den Hout JH, van Ketel BA, et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. //Brain, 1991.-V.114.-P. 761−774.
- Van Zanducke M, Dehaene I. A «cortico-basal degeneration"-like syndrome as a first sign of progressive multifocal leukoencephalopathy. //Acta Neruol. Belg., 2000.-V.100.-P.2442−2445.
- Vanacore N, Bonifati V, Fabbrini G, et al. Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.// Neurol. Sei., 2001.-V.22.-P.97−99.
- Vanacore N, Bonifati V, Fabbrini G, et al. Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. //Neurology, 2000.-V.54.-P.114−119.
- Vanek Z, Jankovic J. Dystonia in corticobasal degeneration.// Mov. Disord., 2001.-V.16.-P.252−257.
- Verin M., Rancurel G., DeMarco O. et al. First familial cases of corticobasal degeneration //Mov.disord., 1997. -V.12. -P.55.
- Verny M., Duyckaerts C., Agid Y. et al. The significance of cortical pathology in progressiv e supranuclear palsy//Brain, 1996. -V.119. -P. 1123−1136.
- Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in Parkinsonian syndromes. //Ann. Neurol., 1994.-V.35.-P.420−426.
- Vila M., Herrero M.T., Levy R. et al. Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. //Neurology, 1996. -V.46. -P.802−809.
- Vingerhoets FJ, Schulzer M, Calne DB, et al. Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion? //Ann. Neurol., 1997.-V.41.-P.58−64.
- Visser L.H., Koudstaal P.J., van der Merwe J.P. Hemiparkinsonism in a patient with primary Sjogren’s syndrome.//Clin. Neurol. Neurosurg, 1993.-V.95.-P.141.
- Watts R.L. Corticobasal degeneration // In: R.L.Watts, W.C.Koller (eds). Movement disorders. New York McGraw-Hill, 1997. -P.451−460.
- Watts RL, Brewer RP. Cortical-basal ganglionic degeneration: classical clinical features and natural history// Mov. Disorders., 1996.-V.11.-P.346.
- Watts RL, William, RS, Growdon JH, et al. Corticobasal ganglionic degeneration.// Neurology, 1985.-V.35(Suppl 1).-P.178.
- Wenning G.K., Ben-Shlomo Y., Magalhaes M., et al. Clinicopathological study of 35 cases of multiple system atrophy// J. Neurol. Neurosurg. Psychiatry, 1995. -V.58. -P. 160−166.
- Wenning G.K., Ben-Solomo Y., Hughes A. et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson’s disease?// J. Neurol. Neurosurg. Psychiatry, 2000. -V.68. -P. 434−440.
- Wenning GK, Ben Shlomo Y, Magalhaes M, et al. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases.// Brain, 1994.-V.117.-P.835−845.
- Wenning GK, Kraft E, Beck R, et al. Cerebellar presentation of multiple system atrophy. //Mov. Disord., 1997.-V.12.-P.115−117.
- Wenning G.K., Litvan I., Jankovic J. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmorten examination // J. Neurol. Neurosurg. Psychiatr. — 1998. — Vol. 64. — P. 184— 189.
- Wenning G.K., Tison F., Elliot L. et al. Olivopontocerebellar pathology in multiple system atrophy //Mov.disord., 1996. -V. 11. -P. 157−162.
- Wenning G.K., Wagner S» Daniel S., et al. Multiple system atrophy //Lancet, 1993. -V.342. -P.681 -685.
- Wichmann T., DeLong M.R. Physiology of the basal ganglia and pathophysiology of movement disorders of basal ganglia origin// In: R.L.Watts, W.C.Koller (eds). Movement Disorders. New York McGraw-Hill, 1997, — P.87−98.
- Wijker M, Wszolek ZK, Wolters EC, et al. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21.// Hum. Mol. Genet., 1996.-V.5.-P.151−154.
- Wilhelmsen K.C., Lynch T., Pavlou E. et al. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21−22.//Am. J. Hum. Genet., 1994. -V.55. -P.l 159−1165.
- Wilson JA, MacLennan WJ. Drug-induced parkinsonism in the elderly.// Age Aging, 1989.-V.18,-P.208
- Winikates J., Jankovic J. Clinical correlates of vascular parkinsonism.//Arch. Neurol., 1999. -V.56. -P.98−102.
- Winikates J., Jankovic J. Vascular progressive supranuclear palsy.// J.Neural. Transm., 1994. -V.42. Suppl. P. 189−201.
- Yamaoka LH, Welsh-Bohmer KA, Hulette CM, et al. Linkage of frontotemporal dementia to chromosome 17: clinical and neuropathological characterization of phenotype.// Am. J. Hum. Genet., 1996.-V.59.-P. 1306−1312.
- Yamauchi H, Fukuyama H, Nagahama Y, et al. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration.// Arch. Neurol., 1998.-V.55.-P.609−614.
- Yekhlef F., Chrysostome V., Sourgen C., et al. How common is multiple system atrophy: a prevalence study in Gironde, France// Mov. Disord., 2000. -V.15(S.3).-P.2
- Yekhlef F., Debras C., Tison F. A case of multiple system atrophy with striatopallidodentate calcification// Mov. Disord., 2000. -V.15(S.3).-P.224.
- Yoshinaga J., Tanaka Y., Satoh Y. et al. Clinical effects of L-DOPS on cerebrovascular parkinsonism.// Movement disorders., 1997. -V.12 (suppl.l). -P.88.
- Zhang L, Murata Y, Ishida R, et al. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. //Nucl. Med. Commun., 2001 .-V.22.-P.767−772.
- Zijlmans J.C., Thijssen H.O., Vogels О.J., et al. MRI in patients with suspected vascular parkinsonism. // Neurology, 1995. V.45. — P. 2183−2188.
- Zijlmans JC, Poels PJ, Duysens J, et al. Quantitative gait analysis in patients with vascular parkinsonism. //Mov. Disord., 1996.-V.11.-P.501−508.